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Background
The prevalence of jumper’s knee is high in sports characterized by high demands on 
leg extensor speed and power, such as volleyball, basketball, football and athletics. A 
prevalence up to 50% has been reported among male, elite volleyball players. The 
complex process from a healthy tendon to jumper’s knee is not fully understood. 
Jumper’s knee is usually described as an overuse injury, although previous studies on 
risk factors are not conclusive. Previous cross-sectional studies among volleyball 
players have found that athletes with jumper’s knee have higher body mass compared 
to asymptomatic controls, suggesting a relationship between body composition and 
jumper’s knee. The “jumper’s knee paradox”, where symptomatic athletes appear to 
perform better in a counter movement jump (CMJ) compared to asymptomatic 
controls, is not fully understood. Tendons adapt to mechanical loading, albeit not 
always adequately. Tendon structural changes from childhood to adulthood are not 
well investigated, and there is a need for prospective studies examining the response to 
intensive training during adolescence. In many athletes with symptoms of jumper’s 
knee, ultrasound or MRI imaging of the painful tendons will reveal morphological 
abnormalities, typically as localized tendon thickening with hypoechoic areas and 
increased vascularity. However, it is not clear whether the presence of ultrasound 
changes in asymptomatic tendons precede (and predict) future tendon problems. 
Aims
First, we wanted to study whether training load and competition load as well as body 
composition or change of body composition represented a risk factor for developing 
jumper’s knee (Paper I). Furthermore, we wanted to investigate jumping ability and 
change of jumping ability as potential risk factors for developing jumper’s knee (Paper 
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ɉ). We also wanted to investigate the relationship between the development of 
ultrasound changes in the patellar and quadriceps tendons and symptoms of jumper’s 
knee, as well as the medium-term effects of intensive training on tendon thickness 
among adolescent athletes (Paper ɒ). 
Methods
Papers ȱ-ɒ were based on a prospective cohort study with a total data collection 
period of 5 years. All participants were recruited from the same cohort, players 
entering the Toppvolley Norway (TVN) program, but the time and duration of 
inclusion differed between participants. TVN is located in Sand, Norway and 
combines an elite volleyball training program with a three-year senior high boarding 
school program. All students at TVN were eligible for this study. In Paper ȱ & ɉ only 
athletes without jumper’s knee at baseline were included, while Paper ɒ also included 
athletes with pre-existing jumper’s knee. The diagnosis of jumper’s knee was based on 
a clinical examination alone. All athletes were examined twice a year. Training 
volume and match exposure were recorded prospectively on a weekly basis. Body 
composition was assessed by measuring height and weight, waist circumference and 
through skin fold caliper tests. Jumping ability was tested on a portable force plate and 
included two different jumps (CMJ and standing jump (SJ)). An ultrasound 
examination was done twice a year as long as students remained at TVN using grey-
scale and color Doppler.  
Main results  
Altogether, 192 students were registered in the school record at TVN during the 5-year 
study period. Nearly one in three boys developed jumper’s knee during their time at 
TVN (32%) compared to only 8% of the girls (Paper I). 
Paper I: Athletes developing jumper’s knee had higher total training volume and 
tendon load compared to those who remained asymptomatic. A multivariate regression 
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analysis showed that match exposure was the strongest sports-related predictor for 
developing jumper’s knee with an OR of 3.88 (95% CI 1.80 to 8.40) for every extra 
set played per week. Volleyball training had an OR 1.72, (95% CI 1.18 to 2.53) when 
combined with match exposure and gender. We did not detect any significant 
differences in body composition at the time of inclusion or change of body 
composition during the study period between players who developed jumper's knee 
and those who did not developed jumper’s knee. Males had three to four times higher 
risk of developing jumper’s knee compared to females, independent on training and 
match exposure in the multivariate regression analysis. 
Paper II: At the time of inclusion, male athletes who went on to develop jumper’s knee 
had significantly better results in CMJ (38.0±5.8 cm) compared to asymptomatic 
males (34.6±5.5 cm, p=0.03), while no difference was detected in SJ. In a multivariate 
logistic regression analysis corrected for gender and previous volleyball training, the 
OR was 2.09 (1.03 to 4.25) per cm difference in CMJ at the time of inclusion. Our 
results did not reveal any significant differences in the change in jumping ability 
between the groups, although both groups improved their jumping performance. 
Paper III: About half of the asymptomatic athletes who went on to develop jumper’s 
knee (17 of 35 tendons) had hypoechoic areas when they started at TVN, while 10% of 
the tendons that remained asymptomatic (24 of 238 tendons) had the same changes. 
Neovascularisation was found in 4% (9 of 238 tendons) of asymptomatic tendons and 
in 48% (15 of 35 tendons) of those who later developed jumper’s knee. In a 
multivariate logistic regression analysis, a baseline finding of a hypoechoic tendon 
area (OR 3.3, 95% CI 1.1 to 9.2) and neovascularisation (OR 2.7, 95% CI 1.1 to 6.5) 
increased the risk of developing jumper’s knee. Patellar tendon thickness among 
healthy athletes did not change (Wilk’s lambda, p=0.07) while quadriceps tendon 
thickness increased (p=0.001). The athletes reported a VISA score of 72 (SD 23) when 
first diagnosed, and knee function did not change during subsequent examinations and 
was 73 (SD 21) when they left TVN. 
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Conclusion
A high volume of volleyball training and match exposure were important risk factors 
for developing jumper’s knee. Body composition or change in body composition were 
not associated with injury risk. Volleyball players with a natural ability for jumping 
high have an increased risk of developing jumper’s knee, while change in jumping 
ability was not identified as a risk factor. Hypoechoic areas and neovascularisation at 
baseline were risk factors for developing jumper’s knee. Quadriceps tendon thickness 
increased 7-11% among healthy athletes, while there was no change in patellar tendon 
thickness. 
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The nomenclature used to characterize different tendon disorders has been confusing, 
at least in part because of a lack of understanding of the underlying pathology. Based 
on previous definitions (Jozsa and Kannus 1997; Khan et al. 1998; Maffulli et al. 
1998; Lian 2006; Hoksrud 2011) the following terminology is used in this thesis: 
Tendinosis is histopathological intratendinous degeneration without clinical or 
histological signs of intratendinous inflammation. The term “tendinosis” is used 
regardless of clinical symptoms, as it can be both symptomatic and asymptomatic.  
Tendinopahty is a condition characterized by a combination of tendon pain and 
tenderness to palpation verified by ultrasound or magnetic resonance imaging (MRI) 
findings demonstrating structural changes in the affected area.  
Patellar tendinopathy means a lesion associated with pain and tenderness at the lower 
point of the patella and with structural changes in the affected area verified by 
ultrasound or MRI.  
Jumper’s knee is a clinically defined condition with exercise-related pain localized at 
the quadriceps insertion to the patella or the patellar tendon and its proximal insertion, 
combined with pain on palpation at the same localization. 
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ADAM A disintegrin and metalloproteinase 
ADAMTS A disintegrin and metalloproteinase with thrombospondin 
AGE Advanced glycation end product 
BMD Body mass density 
CGRP Calcitonin generelated peptide 
CI Confidence interval 
CMJ Counter movement jump 
COX-2 Cyclooxygenase-2 
CSA Cross-sectional area 
ECM Extracellular matrix 
GAGs Glucosaminoglycans  
GLM Global multivariable linear model  
H&E  Hemotoxylin and eosin 
IGF-1 Insuline like growth factor-1 
IL-6 Inter leukin-6 
MMP Matrix metalloproteinase 
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OR Odds ratio  
PDGF Platelet derived growth factor 
PDGFR Platelet-derived growth factor receptor 
PGE2 Prostaglandin E2 
ROM Range of motion 
SD Standard deviation 
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SLRP Small leucine-rich proteoglycans 
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TIMP Tissue inhibitor of matrix metalloproteinase 
TVN Toppvolley Norway  
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VEGF Vascular endothelial growth factor 
VISA-P Victorian institute of sport assessment score – patellar tendon 
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1.1 Anatomy of patellar and quadriceps tendon 
Tendons are anatomic structures interposed between muscles and bones transmitting the force 
created in the muscle to bone, and in this way, making joint movement possible. The anatomy 
of the patellar and quadriceps tendon is described in more detail by several other authors 
(Jozsa and Kannus 1997; Staeubli et al. 1999; Staubli et al. 1999; Kannus 2000; Basso et al. 
2001). A healthy tendon is brilliant white in color and fibro-elastic in texture, showing great 
resistance to mechanical loads. The patellar tendon extends from the lower patellar pole to the 
tibial tuberosity and is the extension of the common tendon of insertion of the quadriceps 
femoris muscle. The patellar tendon width is approximately 3 to 3.5 cm, the thickness is about 
4 to 5mm (Lian et al. 1996; Khan et al. 1998) and the length varies from 5 to 7.5 cm 
depending on the attachment on the patella and tibial tuberosity (Basso et al. 2001). A normal 
adult patellar tendon has a cross-sectional area (CSA) of 1 cm2 (Hansen et al. 2006). The CSA 
of the patellar tendon increases distally (Seynnes et al. 2009). The bulk of the tendon is 
attached to the distal two-thirds of the anterior aspect of the patella with fascicles converging 
in the frontal plane and parallel in the sagittal plane towards their tibial attachments (Basso et 
al. 2001). The length of tendon fascicles varies more with longer anterior fascicles than the 
corresponding posterior fascicles, since the anterior bundles are attached more proximal to the 
patella and more distal to the tibia than the corresponding posterior bundles (Basso et al. 
2001).  
The quadriceps tendon is interposed between the myofascial junctions of the superficial layer 
of the rectus femoris muscle, the middle layers of the vastus medialis and vastus lateralis 
muscles, and the deep layer of the vastus intermedius muscle (Staubli et al. 1999). The layers 
converge to the broad insertion of the quadriceps tendon at the base of the patella. The most 
anterior fibers of the quadriceps tendon blend over the anterior aspect of the patella as 
structural components of the vertical and horizontal tensile bracing system (Staubli et al. 
1999). Biomechanically, the quadriceps tendon and the patella are integral parts of the active 
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and passive extensor mechanisms of the knee joint. Quadriceps tendon thickness is measured 
to 7±1 mm in women and 8±1 mm in men (Staeubli et al. 1999). 
In general, the blood supply of tendons is mainly from the muscle and is usually divided into 
three regions: (i) the musculotendinous junction; (ii) the length of the tendon; (iii) the tendon 
bone junction (O'Brien 1997). The patellar tendon receives its vascularisation from three main 
arterial pedicles (superior, middle and inferior) located on each side of the patellar tendon 
(Soldado et al. 2002; Pang et al. 2009). The vascular network inside the tendon consists of 
longitudinally arranged vessels localized in the endotenon septas together with veins, nerves 
and lymphatics. These small arterioles are oriented parallel to the collagen fibers in the 
endotenon (Aström and Rausing 1995; Khan et al. 1996). The blood supply of the quadriceps 
tendon arises from descending branches of the lateral circumflex femoral artery, by branches 
of the descending geniculate artery and by branches of the medial and lateral superior 
geniculate arteries. Blood vessels penetrate the tendon from the surrounding connective tissue 
and anastomose with a longitudinally orientated intraligamentous network. Compared to the 
surrounding synovial layer, the amount of vessels in the tendon substance is less (Petersen et 
al. 1999). 
 (OHPHQWVRIKXPDQWHQGRQV
Many of the tendons are surrounded by a loose connective tissue called paratenon. Paratenon 
functions as an elastic sleeve permitting free movement of the tendon against the surrounding 
tissues (Hess et al. 1989). The entire tendon is surrounded by a fine connective tissue sheath 
called epitenon. The epitenon is a relatively dense fibrillar network of collagen with strands 
of 8–10 nm in thickness. This network contains longitudinal, oblique, as well as transversal 
fibrils (Kannus 2000). The endotenon is a thin reticular network of connective tissue inside 
the tendon that has a well developed crisscross pattern of collagen fibrils (Kannus 2000). The 
endotenon fibrils invest tendon fibers and bind fibers together.  
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Figure 1: The hierarchical organization of tendon structure. (Reproduced with permission 
from Kannus 2000).  
 
 
 ([WUDFHOOXODUPDWUL[
Tendinous tissue is composed of tendon cells and almost exclusively extracellular matrix 
(ECM) (Kannus 2000). The load bearing elements of tendinous tissue are collagen fibrils that 
are embedded in a hydrated viscous proteglycan-rich substance called ground substance. The 
dry mass of human tendons is approximately 30%, with water accounting for the remaining 
70% of the tendon mass (Kirkendall and Garrett 1997; Kannus 2000). 
Collagen is the abundant protein in tendons, accounting for 65-80% of the dry mass of the 
tendon (Jozsa et al. 1989). Tendons are predominantly made up of collagen type ȱ and smaller 
amounts of other collagen types including type II III, IV (Kadler et al. 1996; Bailey 2001). 
Collagen type I (~60%) is arranged in tensile-resistant fibers, and composed of two Ȑ1- and 
one Ȑ2-chains (Kjaer 2004). It is organized in a complex structure and the structure provides a 
good buffer capacity against longitudinal, transversal horizontal and rotational forces during 
movement (Jozsa et al. 1989). The collagen fiber is the basic force-transmitting unit of the 
tendon, and it determines the mechanical properties of the tendon; small fibrils increase the 
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elastic properties whereas larger fibrils increase the strength (Provenzano and Vanderby 
2006). 
Ground substance surrounds the collagen and elastin molecules and consists of 
polysaccharide chains called GAGs and small leucine-rich proteoglycans (SLRP) which are 
bound to the protein in the form of proteoglycans (O'Brien 1997; Kannus 2000). The large 
glycosaminoglycans have a high number of negatively charged GAGs attached to their core 
protein, which gives these proteglycans the ability to attract and bind water (Fu et al. 2007). 
SLRP constitute about 80% of the total proteoglycan content in the tendon (Samiric et al. 
2004). Their main function is to bind collagen fibrils and regulate fibrillogenesis and they are 
also important for the structure and function of the extracellular matrix (Scott et al. 1981; 
Danielson et al. 1997; Samiric et al. 2004). Any increase in size and concentration or negative 
charges of proteoglycans and GAGs may cause disruption of normal ECM architecture (Scott 
1990). Although the role and function of many of these components are still poorly defined, 
the molecular architecture of the matrix is ideally suited primarily for the transmission of 
tensile load. Tendons also function to stabilize joints and absorb large shocks, protecting 
muscles from damage (Riley 2008). It is clear that the ECM of tendons would adapt to 
mechanical stimulus to make the tissue more damage resistant to ensure an optimal force 
transmission with muscular contractions (Kjaer 2004). 
 7HQGRQFHOOV
The normal tendon tissue has sparse distribution of cells and consists of approximately 95% 
of fibroblasts (tenoblasts and tenocytes) (Aström and Rausing 1995; Kannus 2000). 
Additional cells may include chondocytes, synovial cells and endothelial cells (Jozsa and 
Kannus 1997). The tenocytes are elongated spindle-shaped fibroblasts placed between and in 
parallel with collagen fibrils (Kirkendall and Garrett 1997). In general, fibroblasts are 
attached to the ECM via integrins that span the cell membrane and connect the intracellular 
cytoskeleton with the surrounding matrix: fibroblasts are connected to each other by gap-
junctions (Wang et al. 2006; Chiquet et al. 2009). These cells respond to mechanical stimulus 
by becoming  deformed; they respond to changes in force by altering their function and 
composition (Khan and Scott 2009). The tendon fibroblasts synthesize and maintain the 
elements of extracellular matrix, and therefore the connection between fibroblasts and tendon 
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matrix permits the cells to sense and respond to mechanical stimuli and thus adapt to changed 
patterns of mechanical loading. (Heinemeier and Kjaer 2011). 
1.2 Tendon biomechanics and properties  
Tendons must be able to transmit high muscle force to the skeleton for movement and the 
parallel arrangement of fiber bundles is quite efficient for this purpose. However, tendons 
have low resistance to shear forces. Thus, tendons are designed to transmit forces with 
minimal deformation and energy loss (Kirkendall and Garrett 1997). Tendon dimensions 
(length and cross-sectional area) affect the mechanical properties. Typical parameters 
describing the tendon mechanical properties of tendons were described by Heinemeier and 
Kjaer (2011). Tendon strain describes the elongation and deformation of the tendon relative to 
the normal length (figure 2), while tendon stress describes the tendon force relative to the 
tendon CSA. Thus, tendon stiffness describes the change in tendon length (deformation) in 
relation to the force applied to the tendon. This parameter is dependent on the CSA and length 
of the tendon. i.e. greater CSA and shorter length will lead to greater stiffness. Tendon 
modulus describes the relation between tendon stress and tendon strain. In other words, 
modulus represents the properties of the actual tendon material independently of the CSA. 
This makes it possible to compare structures with different dimensions. A high tendon 
modulus indicates a relatively stiff tissue. Tendon strength is related to tendon CSA but also 
the tensile quality of the tendinous tissue (i.e. intrafibrillar cross links and collagen type 
distribution) (Butler et al. 1978; Kirkendall and Garrett 1997). Therefore, the previously 
described stress/strain curve would depend on the tendon CSA. It is estimated that an increase 
in length of the tendon of more than 4% would lead to microscopic tendon rupture and a total 
rupture would appear at approximately 8-12% of strain (Butler et al. 1978; Wang 2006). 
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Figure 2: Stress-strain curve. The mechanical response of the tendon is defined by the stress-
strain curve. (Reproduced with permission from Wang 2006). 
 

 7HQGRQDGDSWDWLRQWRPHFKDQLFDOORDGLQJ
How tendons adapt to mechanical loading is of great interest. Tendons of athletes have high 
demands and it is important to adapt to increasing training volumes. In spite of the relatively 
low occurrence of fibroblasts and rather limited vascularity, tendons have been shown to be 
metabolically responsive structures. The natural development of tendons from childhood to 
adulthood is not well investigated. Some data from animal studies indicate that tendons of 
immature animals are more likely to hypertrophy than tendons of mature animals (Elliott 
1965; Smith et al. 2002). Since studies among children and adolescents are needed, the 
current knowledge is therefore based on the effect of exercise on adult tendons.  
Investigating tendon adaptation to mechanical loading is challenging. It is suggested that 
endon tissue is protected from rapid changes in tissue mass, while muscle tissue, which is 
known to act as protein store for the organism, is subject to substantial and fast changes in the 
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tissue (Kjaer et al. 2009). The level of collagen synthesis seems to be quite uniform and 
relatively independent of the magnitude of exercises (Kjaer et al. 2009). Change in collagen 
synthesis or structure can be studied in different ways. Animal models have used indirect 
enzymes involved in the formation and processing of collagen, and data suggest that 
increased loading could increase collagen synthesis (Kovanen 1989). Microdialysis technique 
on human tendons using catheters placed near the loaded tendon, found that tendons 
responded to loading. Markers of collagen synthesis are increased in peritendinous tissue for 
2–3 days after an acute training bout and remain elevated with prolonged training (Langberg 
et al. 1999; Langberg et al. 2001). Increased collagen synthesis has also been documented by 
percutaneous biopsies. The mechanism linking mechanical loading of tendon tissue to the 
apparent increase in collagen synthesis is still unknown (Heinemeier and Kjaer 2011) as well 
as the precise link between the tendon metabolic response to increased loading and changes 
observed at macroscopic level. Changes in mechanical properties (CSA, modulus and tendon 
stiffness) have been investigated with ultrasound-based techniques and MRI. As previously 
described, the increase in tendon stiffness could be linked to either changes in material 
properties or increased CSA. Table 1 presents studies investigating changes in tendon 
thickness and CSA as well as tendon stiffness and modulus. 
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 6KRUWWHUPWUDLQLQJHIIHFWV
The evidence from short-term training studies on tendon size is conflicting (Kongsgaard et al. 
2007; Kubo et al. 2009; Seynnes et al. 2009; Kubo et al. 2010; Malliaras et al. 2013). 
Kongsgaard et al. (2007) enrolled 12 untrained 25-yr old men in 12 weeks of resistance 
training 3 times per week, comparing one-leg training with heavy loads (10 sets of 8 
repetitions at 70% of one repetition maximum) in a leg extension machine to the contralateral 
leg training with light loads (10 sets of 36 repetitions with a load equaling the amount of work 
to the work performed by the heavy leg). They concluded that proximal tendon CSA 
increased in both groups. Seynnes et al. (2009) recruited 15 20-yr old university students, 
who at baseline were involved in recreational training 1-2 times/week. After 9 weeks of heavy 
resistance training, patellar tendon cross-sectional area increased by 3.7%. In contrast to these 
findings, Kubo et al. (2009; 2010) have published two studies where they did not find any 
change of CSA. First, they followed a cohort consisting of 10 healthy males for 12 weeks 
(Kubo et al. 2009). The program was isometric knee extension training (4 times per week, at 
70% of maximal voluntary strength with 10 contractions of 15 s duration), and they observed 
no change in CSA or patellar tendon thickness. In the second study they randomized 14 
athletes to a training group using the same training program or to a control group (Kubo et al. 
2010). Training increased muscle strength and they suggested that adaptation of tendon 
properties is slower compared to muscle function. In a recent paper, Malliaras et al. (2013) 
randomized a group of healthy men into 4 different groups (no training, concentric training, 
eccentric training (normal load) and eccentric training (heavy load)). After 12 weeks of 
training they did not find any change in patellar CSA. However, they found modulus to 
increase in all exercise groups but only high load eccentric group had significantly higher 
force, stiffness and modulus compared to the control group. At the 8th International 
Conference on Strength Training in Oslo, Norway in 2012, Seynnes summarized the studies 
available on changes in stiffness, modulus and CSA in response to short-term resistance 
training in the patellar and Achilles tendons. In figure 3 each point represents different studies 
(Kubo et al. 2001; Kubo et al. 2002; Kubo et al. 2003; Reeves et al. 2003; Kubo et al. 2006; 
Kongsgaard et al. 2007; Kubo et al. 2009; Seynnes et al. 2009; Foure et al. 2010). The results 
from previous studies indicate that newly synthesized collagen is deposited into fibrillar 
structure, making tendons stiffer and stronger but that the effect on tendon CSA is not 
unambiguous. 
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Figure 3: Studies available on the effects of short-term resistance training on patellar and 
7Achilles tendon stiffness, modulus and CSA. Significant (filled symbols) and non-significant 
(empty symbols) changes observed after 8 to 15 weeks of resistive exercise. Half-filled symbol 
denotes estimated mean change. (Reproduced with permission from Seynnes 2012). 
 
 
 /RQJWHUPWUDLQLQJHIIHFWV
There are strong indications of tendon adaptation in cross-sectional studies in athletes 
performing long-term load bearing sports. Male runners were found to have ~30% larger 
Achilles tendon CSA than non-runners (Rosager et al. 2002; Magnusson and Kjaer 2003), and 
in a similar study weight-bearing sport athletes had thicker tendons (~20 %) compared to 
athletes in non-weight bearing sports (Kongsgaard et al. 2005). Another research approach 
used to address this question is to study athletes with asymmetric loading patterns of the 
lower extremities, e.g. where the leading leg is consistently subjected to higher loads. Seven 
fencers and badminton players, participating at the elite level for >5 yrs, displayed a side-to-
side isometric knee extensor strength difference of more than 15%, in favor of their lead 
extremity (Couppé et al. 2008). Tendon CSA in lead extremity was also significantly greater 
 13 
 
 
(20-28%) proximally and distally. Furthermore, the lead extremity displayed greater tendon 
stiffness with no difference in modulus, suggesting that the change in mechanical properties 
was largely the result of the increase observed in CSA. There is no long-term randomized 
study on this topic. The only “long-term” training study identified was Hansen et al. (2003), 
who made 11 untrained adults run 70–80 training sessions over a 9-month period without 
detecting any change in Achilles tendon CSA or tendon properties.  
To summarize, tendon material properties (modulus) as well as CSA appear to increase in 
response to long-term loading. However, so far there exists no clear dose-response 
relationship between mechanical load and changes in tendon properties. As described in 
chapter 1.2.2, the common belief is that newly synthesized collagen is deposited into fibrillar 
structure, collagen packing density is increased, making tendons stiffer and stronger and, 
eventually, increasing their cross-sectional area. In Paper III we wanted to examine the 
medium-term effects of intensive loading on tendon thickness among adolescent athletes. 
1.3 Pathology  
 -XPSHU¶VNQHHGLDJQRVLV
Jumper’s knee a is clinically defined condition with exercise-related pain localized at the 
quadriceps insertion to the patella or the patellar tendon and its proximal insertion, combined 
with pain on palpation at the same localization. This terminology was first used by Blazina et 
al. (1973), but the original definition also included the tibial attachment of the patellar 
tendon. The most common site is the proximal part of the patellar tendon (80-95%), even 
if some have reported that up to 25% of cases of jumper’s knee were located in the distal 
insertion of the quadriceps tendon (Fredberg and Bolvig 1999; Hak et al. 2010). On the 
other hand, all 137 new cases of jumper’s knee affected the patellar tendon in a large 
European study among elite football clubs (Hägglund et al. 2011), and only one of 87 athletes 
with jumper’s knee had pain localization in the quadriceps tendon in a Norwegian cross 
sectional study among 613 athletes (Lian et al. 2005). Symptoms typically increase gradually 
and there is often no clear cut-off for when to diagnose jumper’s knee. Even if jumper’s knee 
can be defined as a clinical diagnosis, ultrasound or MRI imaging of the painful tendon will 
reveal morphological abnormalities in many (but not all) painful tendons. Warden et al. 
14
(2007) used ultrasound and MRI to verify 30 athletes with clinical diagnosis with jumpers’ 
knee and a group of 33 activity-matched, asymptomatic controls. They found that tendons 
clinically diagnosed with jumper’s knee had pathological findings evaluated by MRI in 56% 
of the cases and with grey-scale ultrasound in 87% of cases. Hoksrud et al. (2008) examined 
63 patients with 79 symptomatic patellar tendons and did not find any structural changes on 
ultrasound examination in 14% of cases. It is therefore important to note that a study 
population based on a clinical diagnosis of jumper’s knee alone compared to patellar 
tendinopathy verified by ultrasound or MRI, would not include the same patients. 
Evaluation of symptoms 
Blazina et al. (1973) developed the first grading scale for jumper’s knee. This scale was later 
modified by Roels et al. (1978) and Lian et al. (1996). This 5-grade clinical grading system is 
based on the clinical severity of the problem, but is not suited to assess treatment outcomes. 
Table 2: Blazina’s. clinical grading scale (1973), modified by Roels et al. (1978) and Lian et 
al. (1996). 
*UDGH &ODVVLILFDWLRQ
Grade I Pain at the infrapatellar or suprapatellar region after practice or after an 
event 
Grade II  Pain at the beginning of the activity, disappearing after warm-up and 
reappearing after completion of activity  
Grade IIIa Pain during and after activity, but the patient is able to participate in 
sports at the same level  
Grade IIIb Pain during and after activity and the patient is unable to participate in 
sports at the same level  
Grade IV        Complete rupture of the tendon  
VISA-P score 
The Victorian Institute of Sport Assessment (VISA) score was designed specifically to 
quantify knee function in subjects with patellar tendinopathy and has also been shown to be a 
reliable and valid measure (Cook et al. 1998; Visentini et al. 1998; Khan et al. 
1999). It was originally designed to be an index of severity of symptoms in patients with 
jumper's knee but today there is also a version for the Achilles tendon (VISA-A) (Robinson 
et al. 2001). Therefore, the knee score has been denoted to VISA-P to avoid 
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confusion. This self-recording questionnaire is designed specifically to quantify knee function 
in subjects with patellar tendinopathy, and assesses symptoms, simple tests of function, and 
the ability to play sports. Six out of eight questions are scored on a scale from 0 to 10 with 10 
representing optimal health. The maximal VISA-P score for an asymptomatic, fully 
performing individual is 100 points and the theoretical minimum is 0. Symptoms reported by 
adult, elite volleyball players with jumper’s knee are 60 to 80 points in patients enrolled in 
non-operative clinical trials (Lian et al. 2005; Visnes et al. 2005; Hoksrud and Bahr 2011; 
Zwerver et al. 2011; Zwerver et al. 2011), and candidates for surgery typically have VISA-P 
score ranging from 30 to 50 points (Bahr et al. 2006; Hoksrud and Bahr 2011; Pascarella et al. 
2011; Maier et al. 2013). The VISA score appears to be the simplest and most reliable 
questionnaire available today for monitoring clinical and functional changes over time with 
minimal investigator’s influence (Marcheggiani Muccioli et al. 2013). VISA is well suited to 
evaluate progression of symptoms and also evaluate outcome after treatment (Visentini et al. 
1998; Robinson et al. 2001).  
Visual analogue scale (VAS) 
A 100 mm VAS has been used widely as outcome measure for pain. VAS has been shown to 
be reliable and valid (Price et al. 1983), and it is commonly used to evaluate the effect of 
different treatment regimes. The limitation with VAS is that it does not take into account the 
activity level and change of activity level in athletes, especially since these symptoms in these 
cases are clearly related to activity. To compensate, pain might be recorded more specifically 
i.e. pain under activity or average pain during day. Still, this makes comparisons between 
different treatment studies difficult.  
 (SLGHPLRORJ\RIMXPSHU¶VNQHH
The prevalence of jumper’s knee is high, up to 40-50%, in sports characterized by high 
demands on leg extensor speed and power, such as volleyball, basketball, football and 
athletics (Ferretti et al. 1990; Lian et al. 2005). Volleyball players are more susceptible for 
jumper’s knee compared to other athletes (Lian et al. 2005; Zwerver et al. 2011). Lian et al. 
(2005) published a cross-sectional study among 9 different elite sports and 613 athletes in 
Norway. They found that the overall prevalence of jumper’s knee was 14% across the sports 
included. In addition, 8% of the athletes reported previous symptoms, indicating that every 
16
fifth elite athlete is affected by jumper’s knee during his or her athletic career. The prevalence 
varied from no cases in cycling and orienteering to 45% with current symptoms in male 
volleyball. Zwerver et al. (2011) investigated non-elite athletes in 7 different sports in the 
Netherlands. They found that the prevalence of jumper’s knee varied between 2.5% (football) 
and 14.4% (volleyball), and the overall prevalence in the survey was 8.5%. The main 
limitation of these two studies is that the athletes with the most serious problems, those who 
could not participate in training or competition, were not included in the study. Thus, the 
samples represent the survivors especially at the elite level, and the true career prevalence is 
higher than reported. Prevalence data among adolescents are limited. Among elite junior 
volleyball players in Sweden, age 17 yrs, , the prevalence was reported as 14% (Gisslen et al. 
2005). This prevalence was higher than the 7% Cook et al. reported in a group of 14–18 yrs 
male and female basketball players (Cook et al. 2000). Incidence data of jumper’s knee is not 
notably evident, since it is not always clear when the injury occurs. In a retrospective study of 
100 athletes with jumper’s knee who presented to a sports medicine clinic 56% had developed 
symptoms before the age of 20 (Cook et al. 1997). Data from European elite football clubs on 
2229 male athletes found an incidence of 0.12 injuries per 1000 hours of total exposure and 
an overall prevalence of 2-3% (Hägglund et al. 2011). However, this study only registered 
time loss injuries and therefore the definition of injury is different. They also reported a high 
recurrence rate (12%-27%) and this probably reflects the chronic and recurrent character of 
the condition. On the other hand, studies from Danish elite male football show that 7% of 
players (3% to 7% of patellar tendons) developed symptomatic jumper’s knee during a season 
(Fredberg and Bolvig 2002; Fredberg et al. 2008). Interestingly, as many as 6% of players 
(3% of patellar tendons) reported time loss attributable to jumper’s knee (Fredberg et al. 
2008), indicating that over the season a majority of players with jumper’s knee developed 
symptoms severe enough to limit performance and lead to missed training or match exposure. 
Table 3 summarizes the data on the prevalence, incidence and severity of jumper’s knee. 
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The severity of jumper’s knee is difficult to quantify. Overuse injuries are difficult to record 
in epidemiological studies, especially when standard methods of injury registration are used, 
typically relying on a “time-loss” injury (Bahr 2009). Jumper’s knee symptoms such as pain 
or functional limitation most often appear gradually and may be transient in nature. Therefore 
it is likely that athletes will continue to train and compete despite the presence of overuse 
conditions, at least in the early phase. Thus, it is likely that few overuse injuries lead to time-
loss from sport (Clarsen et al. 2013). Overuse problems should therefore be expressed using 
prevalence and severity measures, rather than as the incidence of time-loss injuries (Bahr 
2009; Clarsen et al. 2013). In volleyball and beach volleyball the prevalence and severity of 
overuse injuries such as jumper’s knee is high, while the number of time-loss injuries is low 
(Bahr and Reeser 2003; Bahr 2009; Clarsen et al. 2013). The mean duration of jumper’s knee 
symptoms varied in two cross-sectional studies between 19-32 months and the mean VISA 
score in the same studies was 64-71 (Lian et al. 2005; Zwerver et al. 2011). Long duration of 
symptoms has been described by other studies (Willberg et al. 2011; Hoksrud et al. 2012; van 
der Worp et al. 2013) and has previously been reported as high as up to 72 months (Visnes et 
al. 2005). Despite the high prevalence in cross sectional studies among top athletes, the 
number of athletes retiring from sports because of their problems with jumper’s knee is 
unknown. To investigate the long-term prognosis of jumper’s knee, Kettunen et al. (2002) 
followed 36 athletes from a previous case–control study for 15 years. They found that as 
many as 53% of athletes with jumper’s knee were forced into retirement. However, 15 years 
later jumper’s knee caused mild pain during daily activities. However, there was no difference 
in work ability or current physical leisure time activity between the athletes with or without 
previous jumper’s knee. 
 ,PDJLQJRISDWKRORJLFDOWHQGRQV
Ultrasound and MRI visualize anatomic structures of the tendon very well, and demonstrate 
structural changes in tendinopathic tendons. Ultrasound changes described in tendinopathic 
tendons typically include localized tendon thickening with hypoechoic areas and increased 
vascularity (Khan et al. 1996; Lian et al. 1996; Cook et al. 1998; Cook et al. 2000; Cook et al. 
2001; Cook et al. 2004; Malliaras et al. 2006; Comin et al. 2013). Ultrasound changes are 
usually seen in the deep proximal part of the tendon. The pathological tendon is thicker 
compared to the normal tendon. The increased thickness and hypoechoic areas may be 
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explained by increased extracellular matrix synthesis, disorganisation of matrix and increased 
water content. However, as early as in 1996, cross-sectional studies by Khan et al. (1996) and 
Lian et al. (1996) revealed no one-to-one relationship exists between pain and structural 
changes. They observed that not only were there symptomatic tendons with normal tendon 
morphology on ultrasound examination, but also that asymptomatic tendons with tendon 
thickening and hypoechoic areas were not uncommon. Khan et al. (1996) found that all 28 
symptomatic tendon had hypoechoic areas while 4 of 22 tendons in athletes who had never 
reported  any problems had these changes. Lian et al. (1996) examined Norwegian elite 
volleyball players. They found that 7 of the 30 knees with a clinical of jumper's knee 
diagnosis in the patellar tendon had normal ultrasound findings, and whereas ultrasound 
changes believed to be associated with jumper's knee (tendon thickening, echo signal 
changes, irregular paratenon appearance) were observed in 12 of 51 knees without symptoms. 
These findings have also been reproduced in subsequent cross-sectional studies (Cook et al. 
1998; Cook et al. 2000; Warden et al. 2007).  
Modern ultrasound-based imaging technology (color Doppler sonography) showed that 
chronic painful Achilles tendons include increased blood flow and perfusion (called 
neovascularization) intratendinously, peritendinously, or both (Öhberg et al. 2001). Normal 
tendon and osseotendinous junction display a low blood flow, evidenced by minimal colour 
Doppler activity, whereas tendinopathic tendon displays increased colour Doppler activity 
and up to three times the number of intratendinous microvessels.(Öhberg et al. 2001; Scott et 
al. 2008). Weinberg et al (1998) were the first to describe their experience with color Doppler 
ultrasound in the evaluation of patellar tendinosis. They found that in 20 symptomatic tendons 
from 14 patients, 11 had a proximal hypoechoic area, 12 had a thickened proximal patellar tendon 
and all but 1 of 25 these exhibited increased blood flow. Öhberg et al. (2001) examined 28 
Achilles tendons (21 patients) with a painful mid-portion condition as well as 20 normal 
(pain-free) tendons, and these were examined with grey-scale ultrasonography combined with 
color Doppler examination. In all painful tendons, but not in any of the normal pain-free 
tendons, neovascularisation was seen in the area with tendon changes (localised widening of 
the tendon with focal hypoechoic areas). These findings have later been described in the 
patellar tendon as well (Cook et al. 2004; Alfredson and Öhberg 2005; Gisslen and Alfredson 
2005; Hoksrud et al. 2006). It is difficult to know if this neovascularisation represents genuine 
neoangiogenesis; however, in histological studies of chronic tendinopathy angiogenesis is a 
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common finding (Rees et al. 2013). Still, the relation between the color Doppler findings and 
clinical severity is unclear (de Vos et al. 2007; Hoksrud et al. 2008; Tol et al. 2012).  
It is not clear whether the presence of ultrasound changes in asymptomatic tendons precede 
(and predict) future tendon problems, and longitudinal studies have conflicting results (Cook 
et al. 2001; Fredberg and Bolvig 2002; Gisslen and Alfredson 2005; Gisslen et al. 2005). In 
Paper III, we therefore wanted to investigate whether  hypoechoic areas and 
neovascularisation represented risk factors for jumper’s knee in a large cohort of elite 
adolescent volleyball players and also to investigate the correlation between tendon pain and 
ultrasound findings. 
 +LVWRSDWKRORJLFDOILQGLQJV
The histopathological findings in biopsies from tendinopathy tendons are consistent, and the 
pathological changes in patellar, Achilles and supraspinatus tendinopathy have been shown to 
be similar (Khan et al. 1999; Maffulli et al. 2004). As shown in light microscopy, tendon from 
patients with chronic patellar tendinopathy differs from normal tendon in several key ways. 
The changes in ECM composition, including increased ECM synthesis, disorganisation of 
matrix and increased water content are supported by most authors even though some have 
found conflicting results. Puddu et al. (1976) first documented that the pathology in tendons 
clinically known as “Achilles tendonitis” was characterized by an absence of inflammatory 
cells in or around the lesion but instead a separation and fragmentation of collagen, which he 
labeled “tendinosis”. The tendons display a loss of collagen continuity and appear amorphous 
and disorganized with collagen replaced by degenerative and necrotic tissue (Khan et al. 
1998).  
Parkinson et al. (2010) compared normal human tendon tissue obtained from patients 
undergoing ACL reconstruction using a patellar tendon graft with abnormal tendon tissue 
obtained from patients undergoing a surgical procedure for patellar tendinopathy. They found 
that the rate of synthesis of proteoglycans is 25-fold greater in abnormal patellar tendons than 
in normal tissue. This was due to the significant increase in the synthesis of the large 
proteoglycans aggrecan and versican in abnormal tissue, whereas negligible levels of these 
proteoglycans were synthesized in normal tissue. Normal tissue predominantly synthesized 
SLRP. The increase in the synthesis of large proteoglycans by abnormal tissue was reflected 
in greater tissue levels of large proteoglycans in the matrix of tendons in human patellar 
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tendinopathy. Scott et al. (2008) had tendon biopsies from 21 patients with documented 
patellar tendinosis and from 10 control participants with healthy tendons operated with 
intramedullary nailing for low-energy tibia fractures. The major finding was that elevations in 
versican levels contribute to the increased ECM volume in symptomatic patellar tendinosis. 
This is consistent with the results of previous studies showing increased levels of large 
proteoglycans associated with overuse tendinopathy. Samiric et al. (2009) had similar 
findings when they examined 25 pathological tendons and 23 normal tendons and found 
increased water content and GAGs levels in patellar tendinopathy compared to normal tissue. 
Nerve sprouting and change in the distribution and type of nerves have also been reported in 
tendinopathic tissue (Lian et al. 2006; Danielson 2009). Lian et al. (2006) had biopsies from 
the patellar tendon in 10 patients with patellar tendinopathy and 10 from a control group 
without any previous or current knee symptoms compatible with patellar tendinopathy. They 
found an increased occurrence of sprouting nonvascular sensory substance P-positive nerve 
fibers and a decreased occurrence of vascular sympathetic nerve fibers, positive to tyroxin 
hydroxylase, a marker for noradrenaline. Their conclusion was that altered sensory-
sympathetic innervation suggests a role in the pathophysiology of tendinopathy, and that 
ingrowth of sprouting substance P fibers presumably reflects a nociceptive and maybe a 
proliferative role. Lian et al. (2007) also found that there was a significantly higher number of 
apoptotic cells per unit area and a significantly higher apoptotic index in biopsy specimens 
from the patellar tendons in patients with patellar tendinopathy compared with controls. The 
role of apoptotic cells is unclear and need further research. 
 0ROHFXODUILQGLQJV
Biochemical and molecular studies of chronic tendinopathy during the last 15-20 years have 
increased our understanding of underlying pathology, focusing in changes in factors 
regulating ECM, enzymes and cytokines and signalling factors. In order to maintain 
homeostasis, the ECM is regulated by a number of complex enzyme systems. 
These have been investigated in animal studies like Samiric et al. (2004), where they 
examined tendons from 1- to 2-year-old steer. They found the continual process of matrix 
remodeling is a constitutive (albeit slow) activity in normal tendons, affecting proteoglycans 
in addition to collagen, and is thought to be primarily mediated by metalloproteinases acting 
in the extracellular environment, such as matrix metalloproteinases (MMPs) and a disintegrin 
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and metalloproteinase with thrombospondin motifs (ADAMTS). Briefly, there are 23 MMPs 
in humans, which have a wide range of matrix substrates and several of these enzymes have 
activity against fibrillar collagen. Studies from human tissue found that increased levels of 
different MMPs and ADAMTS are likely to be responsible for the breakdown and 
disorganization in ECM (collagen and proteoglycans) in tendinopathic tendons (Jones and 
Riley 2005; Nagase et al. 2006). Proteoglycans are primarily degraded by enzymes of the 
ADAMTS family known as ”aggrecanases”, but precisely which enzyme is involved in the 
turnover of tendon proteoglycan is currently unknown. Jones et al. (2006) sampled normal 
tendons from 32 men where 11 tendons were normal, 9 painful, and 12 ruptured Achilles 
tendons and found that almost all of the 23 MMP and 19 ADAMTS family members were 
detectable in normal tendon, although levels of expression varied widely. They also examined 
the mRNA profile from these samples and different mRNA characteristic profiles between the 
groups. They were also able to identify a number of genes worthy of further study. Fu et al. 
(2002) compared 11 patellar tendons from patients operated for patellar tendinopathy with 12 
controls operated undergoing ACL reconstruction using a healthy patellar tendon as an 
autograft indicating that collagen disturbances in human patellar tendinosis may be related to 
augmented collagenolysis and a high MMP1 expression. MMP1, ubiquitous in soft tissues, is 
one of the collagenases with proteolytic activity in type I collagen, the most abundant 
collagen in tendons. The same authors published from the same material (Fu et al. 2002) that 
in tendinosis samples immunopositive cells for cyclooxygenase-2 (COX-2) and transforming 
growth factor-beta1 were significantly higher than those of the control subjects. Tendinosis 
fibroblast culture also produced more prostaglandin E2 and active transforming growth 
factor-beta1. These findings indicate the involvement of prostaglandins and cytokines that 
may explain the clinical symptoms and nonhealing features of tendinosis.  
Different cytokines and signalling factors like increased level of transforming growth factor–
ȕ (TGF- ȕ), platelet-derived growth factor (PGDF) and COX-2 are signalling factors also 
stimulating synthesis of the ECM (Fu et al. 2002; Fu et al. 2002; Riley 2008). Other signal 
factors stimulating general cell proliferation (tenocyte proliferation, angiogenesis and nerve 
sprouting) have been demonstrated in tendinopathic tendons (glutamate, substance P, insulin 
growth factor-1, vascular endothelial growth factor (VEGF), mast cell tryptase (Fu et al. 
2002; Lian et al. 2006; Riley 2008; Scott et al. 2008). Scott et al. (2008) and Lian et al. 
(2006), as previously described, found elevations in versican levels contributing to the 
increased extracellular matrix volume in symptomatic patellar tendinosis. Up-regulation of 
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glutamate and its receptor NMDAR1 in the tendinopathic tendons has also been demonstrated 
(Alfredson et al. 2000; Alfredson et al. 2001; Schizas et al. 2012). Alfredson et al. (2000; 
2001) used microdialysis technique in two small case-control studies (extensor carpi radialis 
brevis, n=8, and patellar tendon, n=10), and found that tendinopathic tendons had higher 
concentrations of the excitatory neurotransmitter glutamate, but not prostaglandin E2. A 
cornerstone in the degenerative model of tendinopathy is therefore the absence of 
inflammatory cells. 
Schizas et al. (2012) had biopsies from 10 patellar tendons and 8 controls and concluded that 
tendinopathic tendons had up-regulation and activation of glutamate receptors in painful 
tendinosis. The increased level of glutamate is suggested to give cell proliferative effects seen 
as angiogenesis, tenocyte transformation and nerve sprouting and thereby stimulating 
neovascularisation in tendinopathic tendons (Alfredson and Lorentzon 2003). Glutamate is 
also a potent modulator for pain and is suggested to be implicated in tendinopathic pain. 
Substance P is another modulator for pain by transmitting nociceptive information and the 
level is increased in these tendons (Lian et al. 2006; Scott and Bahr 2009). In addition, 
substance P may play a role in healing the tendon by its stimulation of fibroblast proliferation 
and angiogenesis, but also activate mast cells and release histamine and thereby stimulate 
nerve endings and cause a process called neurogenic inflammation (Lian et al. 2006; Scott 
and Bahr 2009).  
Riley (2008) has summarized this complex regulation and remodelling of the tendon matrix 
(fig.4). Enzymes like MMP have a key role in the regulation of the activity of tendon cells 
and matrix remodelling in both normal and pathologic tendon. In a pathological tendon the 
excessive or inappropriate activity of enzymes, cytokines and signalling factors and 
destructive matrix-degrading enzymes lead to tendinopathy.  
Figure 4. Major molecular changes that have been identified by gene-expression studies, 
protein analysis or both are summarized (Riley 2008). Molecules for which expression levels 
are increased are denoted by an upwards arrow, molecules for which expression levels are 
decreased are denoted by a downwards arrow and molecules for which expression levels 
remain unchanged are denoted by a horizontal arrow. Photomicrograph (A) is an alcian 
blue/H&E-stained section of supraspinatus tendinopathy, showing proteoglycans stained 
blue. Photomicrograph (B) is an H&E-stained section of Achilles tendinopathy, showing 
increased cellularity and proliferation of blood vessels. Abbreviations: ADAM, a disintegrin 
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and metalloproteinase; ADAMTS, ADAM with thrombospondin motifs; AGE, advanced 
glycation end product; COX2, cyclooxygenase 2; H&E, hemotoxylin and eosin; IGF-I, 
insulin-like growth factor 1; MMP, matrix metalloproteinase; NMDAR, N-methyl-D-
aspartate receptor; PDGFR, platelet-derived growth factor receptor; PGE2, prostaglandin 
E2; TGF-ȕ, transforming growth factor ȕ; TGF-ȕR1, TGF-ȕ type 1 receptor; VEGF, vascular 
endothelial growth factor. Reproduced with permission from Riley 2000). 
 0RGHOVRIWHQGLQRSDWK\
Synthesizing the data available on the histopathological and biological changes observed in 
tendinopathic tendons into a model explaining how and why tendinopathy develops, is not an 
easy task. In 1992, Leadbetter (1992) suggested that tendons develop tendinosis because of a 
“failed tendon healing response”. He proposed that inadequate adaptation (i.e. microtrauma) 
to tendon load preceded the moment of conscious injury. With continued overexertion and the 
accumulation of repetitive scar adhesions, degenerative change, and adverse effects of chronic 
microtrauma recovery from this problem will be slow. Khan et al (1998) and Bahr (2009) 
have used this model to point out that with overuse injuries the pathological process is often 
under way for a period of time before the athletes notices the symptom. Figure 5 presents a 
hypothetical overview of the time course of onset of tissue injury and pain in a typical 
overuse injury (Khan et al. 1998; Bahr 2009). 
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Figure 5: Pain 
profile of 
typical of 
overuse tendon 
injury”. 
(Reproduced 
with permission 
from Bahr 
2009)  
In 2009, Cook and Purdam (2009) presented their continuum model of tendinopathy. This 
model suggests that the pathological process can be described in three stages: reactive 
tendinopathy, tendon dysrepair (failed healing) and degenerative tendinopathy. Stage one is a 
non-inflammatory proliferative response in the cell and matrix, occurring with acute overload. 
This results in a short-term adaptive and relatively homogeneous thickening of a portion of 
the tendon that will either reduce stress (force/unit area) by increasing the cross-sectional area 
or allow adaptation to compression. There is ECM change due to an increase in bound water. 
Collagen integrity is mostly maintained, and the authors speculate that these initial changes in 
ground substance in reactive tendinopathy occur because quick adaptation is necessary until 
longer-term change in either structure or mechanical properties (true adaptation) happens. 
Tendon dysrepair is stage two and describes the attempt at tendon healing, similar to reactive 
tendinopathy but with greater matrix breakdown. The increase in proteoglycans results in 
separation of the collagen and disorganization of the matrix. The changes are somewhat more 
focal and matrix changes more varied than in the reactive stage. There may also be an 
increase in vascularity and associated neuronal ingrowth. Degenerative tendinopathy is 
thought to represent stage three, with progression of both matrix and cell changes as seen in 
histopathological studies. Areas of cell death due to apoptosis, trauma or tenocyte exhaustion 
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are apparent. Large areas of the matrix are disordered and filled with vessels, matrix 
breakdown products and little collagen. According to Cook and Purdam (2009), there is little 
capacity for reversibility of pathological changes at this stage. 
Recently, Rees et al. (2013) suggested that there may be a need to revisit the role of 
inflammation in the development of tendinopathy. They argue that the “tendinosis” paradigm 
oversimplifies our understanding of the pathological process. Even if inflammatory cells is 
not the dominant pathology in established tendinopathy, they suggest that it is likely that 
elements of the inflammatory response play a role in the progression or continuation of 
tendon dysrepair. Since mechanical overload is likely to be the dominant factor at least at one 
point, some of the damage is mediated through a process that involves elements of the 
inflammatory process, according to their hypothesis. 
To summarize, current knowledge of why and how tendinopathy develops is incomplete. Too 
much load of the tendon is probably an important factor that may initiate a cascade of events, 
still there is no model of tendinopathy describing the complete process from a healthy tendon 
to tendinopathy. The process is often gradual and bilateral, and the pathological changes are 
thought to occur before tendons become symptomatic. 
The main limitation with our current evidence is that little research has been conducted in 
early-stage tendinopathy -therefore the complex interactions between the cell and matrix and 
systemic and local factors in the transition from healthy to end-stage tendinopathy need 
further investigation. So far, no high-quality animal model has been developed, and future 
research is needed to develop a model where tendinopathy may be induced and investigated 
in all phases. Repetitive biopsies or imaging studies from an asymptomatic tendon until 
tendinopathy have not been done, for obvious reasons. Previous case-control studies and 
cross-sectional studies on humans have been based merely on static histopathology in chronic 
tendons scheduled for surgery. Tendon pain is another difficult topic which is not properly 
explained in any model of tendinopathy (Khan and Cook 2000; Khan et al. 2006). Although 
molecular research has identified changed levels of enzymes, cytokines and signaling factors 
(i.e. substance P and glutamate) in end-stage tendinopathy (Lian et al. 2006) many tendons 
with histopathological findings of tendinosis are pain free (Kannus and Jozsa 1991). 
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1.4 Injury prevention 
An injury prevention research model has been described by van Mechelen (1992) as a four-
step sequence. Firstly, the magnitude of the problem must be identified and described in terms 
of its incidence and severity. Secondly, the risk factors and injury mechanisms that play a part 
in the occurrence must be identified. In practical term this means establishing the causes of 
injury. The third step is to introduce measures that are likely to reduce the future risk and/or 
severity. Such measures should be based on information on the aetiological factors and the 
injury mechanisms as identified in the second step. Finally, the effect of the measures must be 
evaluated by repeating the first step, which can be achieved by time trend analysis of injury 
patterns or, preferably, by means of a randomised clinical trial (Bahr and Krosshaug 2005). 
The magnitude i.e. prevalence of the problem of jumper’s knee, was presented in chapter 
1.3.2. The etiology of tendinopathy, as described in chapter 1.3.4-1.3.6, is complex and far 
from well understood. However, even if the underlying pathophysiology is poorly understood, 
it may be possible to point out some important etiological factors. Meeuwisse (1994) 
introduced a model to understand the multifactorial causation of sport injuries, where he 
proposed that intrinsic risk factors are predisposing factors that may be necessary, but seldom 
sufficient, to provoke an injury. The intrinsic and extrinsic risk factors contribute towards 
athlete susceptibility to injuries, but are usually distant from the time of injury and rarely 
sufficient as a cause of injury alone. It is the sum of, as well as the interactions between, these 
factors that cause the athlete to be injured. Lian (2006) applied the model of Meeuwisse 
(1994) Bahr and Krosshaug (2005) to the case jumper’ s knee. In figure 6 the most important 
potential risk factors are summarized. The role of inciting event is unclear, but in the etiology 
of jumper’s knee, there is not a single event but the sum of events that might cause the athlete 
to be injured. 
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Figure 6. A dynamic, multifactorial model of the etiology of jumper’s knee (Reproduced with 
permission from Lian 2006) 
1.5 Risk factors for jumper’s knee 
The results of  the literature search until the start of the study in 2006 on the risk factors for 
jumper’s knee are presented in table 4. The following text summarizes the main findings.  
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 7UDLQLQJYROXPH	PDWFKH[SRVXUH
There are three studies showing an association with the amount of training and playing 
(Ferretti et al. 1984; Lian et al. 1996; Gaida et al. 2004) and two with no association to the 
risk of developing jumper’s knee (Lian et al. 2003; Malliaras et al. 2006). Feretti et al. (1984) 
studied a sample of 407 volleyball players chosen randomly from different levels of the 
Italian leagues. As many as 93 of 407 (23%) were suffering or had suffered from jumper’s 
knee. They found a close relationship between the number of weekly training sessions and 
jumper’s knee. Prevalence among players who trained more than 4 times a week was over 
40%. Lian et al. (1996) examined 141 well-trained volleyball players, of which 55 (39%) 
satisfied the diagnostic criteria for jumper’s knee. They found that athletes with jumper’s 
knee trained a significant higher number of volleyball sessions per week (4.4±1.0) than 
athletes without symptoms (3.9±1.0). Gaida et al. (2004) investigated 39 elite female 
basketball players with patellar tendinopathy. The 24 asymptomatic controls trained 
significantly less during the last 6 months (9±3 h/week) compared to athletes with patellar 
tendinopathy symptoms (12±5 h/week). On the other hand, Lian et al. (2003) examined 47 
athletes in a high-level volleyball tournament and found 24 with current symptoms (55%) and 
20 without any symptoms and three with previous symptoms. In this study they did not find 
any difference in volleyball training per week or career length. However, they found a 
difference in the weekly volume of weight training (jumper’ knee: 4.5±2.8, controls: 2.3±2.3). 
Malliaras et al. (2006) found no difference in weekly activity level and number of years of 
volleyball competition in 113 male and female volleyball players. The volume of strength 
training was not associated with jumper’s knee in two studies (Ferretti et al. 1984; Lian et al. 
1996), whereas in another study (Lian et al. 2003), doing more strength training was 
associated with jumper’s knee. Two studies found no association between the amount of jump 
training and jumper’s knee (Lian et al. 1996; Lian et al. 2003). It has been hypothesized that a 
sudden change and increase in the volume of training when young, promising players are 
promoted from the junior to the senior level can increase the risk of jumper’s knee (Reeser et 
al. 2006). Perhaps athletes that increase their training volume the most also have the highest 
risk of developing jumper’s knee (Lian et al. 2003; Reeser et al. 2006). Early sports 
specialization is a contentious issue (Malina 2010; Capranica and Millard-Stafford 2011; 
Moesch et al. 2011). One question is whether varied sports participation during adolescence 
can protect against overuse injuries, because relatively little evidence exists regarding the 
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long-term medical effects of rigorous training and competitive schedules on children in 
specific sports.  
Most of the data available on the relationship between training/competition load are from 
cross-sectional or case-control studies. These research question needs to be addressed in 
prospective studies. Therefore in Paper I we wanted to investigate whether  training volume 
and match exposure were risk factors for developing jumper’s knee. 
 %RG\FRPSRVLWLRQ
A cross-sectional study among volleyball players showed that athletes that had developed 
jumper’s knee had higher body mass compared to asymptomatic controls (Lian et al. 1996). In 
this study there was no data on body composition (fat mass vs muscle mass), but the 
participants were described as well trained athletes. The higher body mass was therefore 
assumed to represents higher muscle mass, perhaps causing tendinopathy through higher load 
on the patellar tendon. Lian et al. (2003) found the same association in another cross-sectional 
study, where subjects with jumper’s knee were on average heavier than subjects without 
jumper’s knee. None of these two studies (Lian et al. 1996; Lian et al. 2003) found an 
association between body height and jumper’s knee. Cook et al. (2004) found no difference in 
height, weight, skinfolds, or arm span/height between 135 junior elite basketball players with 
and without jumper’s knee. Gaida et al. (2004) found that athletes with unilateral patellar 
tendinopathy had a higher waist to hip ratio than controls in their cross-sectional study among 
female basketball players. This indicates a larger abdominal fat distribution relative to 
gluteofemoral fat deposits. Human fat distribution is controlled by a complex interaction of 
hormones and is particularly influenced by the female sex hormones (oestrogen and 
progesterone), but the mechanisms whereby hormones control this fat distribution are unclear. 
Why there were no detectable differences between the bilateral group and controls in any of 
the measured variables is not explained, and only subjects in the unilateral group were 
distinguished from the control group. In the general population previous studies have found a 
correlation of tendinopathy and body composition (Wendelboe et al. 2004; Werner et al. 
2005). Wendelboe et al. (2004) compared three hundred and eleven patients who underwent 
shoulder surgery with 933 age and frequency-matched controls. They found that individuals 
who are obese are at increased risk for “rotator cuff tendinitis” and rotator cuff-related 
surgery, but it is important that most of these cases had a body mass index (BMI) higher than 
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30. Werner et al. (2005) found similar results in their cohort including 501 active workers
followed for an average of 5 years.  
We therefore do not know if fat mass and body composition represents a risk factor in well-
trained athletes. In Paper I, we wanted to investigate if body composition or change of body 
composition was a risk factor for developing jumper’s knee in a cohort of adolescents 
athletes. 
 *HQGHU
Ferretti et al. (1984) concluded that there was no difference between the incidence of 
jumper’s knee in males and females, and the slightly higher rate in males could be attributed 
in part to more training in males. Witvrouw et al. (2001) followed a cohort of 138 athletes. 
During the 2-year study period of the study “patellar tendinitis” was diagnosed in 19 (13.8%) 
of the 138 students. Of the 99 boys, 11 developed “patellar tendinitis”, as did 8 of the 39 girls. 
Statistical analysis showed no significant sex difference in the incidence of “patellar 
tendinitis” in this study (p=0.36). In contrast, Lian et al. (2005) examined 613 male and 
female athletes at the national elite level from different sports (athletics, basketball, ice 
hockey, volleyball, orienteering, road cycling, wrestling) but football and team handball were 
the only sports where both gender were investigated. They found male gender to be an 
intrinsic risk factor, because the prevalence of current jumper’s knee in female handball and 
female soccer was 2.4 times lower compared with the corresponding male sports. 
Prior to 2006 there is limited epidemiological evidence to substantiate the claim for a gender 
difference. Still, some hypotheses have been postulated to explain potential gender 
differences. A biomechanical approach would be that women have less quadriceps strength 
and inferior jumping capacity, so the patellar tendon is exposed to lower forces. However, 
thickness and CSA of the tendon is smaller in female and therefore the tendon stiffness, 
which is dependent on the CSA, might not be different between the genders. So far it is 
unknown if jump height is a more important determinant of patellar tendon loading than sex. 
If different hormone concentrations might influence susceptibility to tendinopathy between 
gender is another approach (Gaida et al. 2004). There is no obvious hormonal explanation for 
males having a higher prevalence than females, since studies indicate that estrogen inhibits 
exercise induced collagen synthesis and then leads to a lower rate of tendon tissue repair. 
Miller et al. (2007) investigated the tendon collagen fractional synthesis rate in healthy male 
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and females and concluded that both in the resting state and after exercise, tendon collagen 
synthesis was lower in women than in men. Hansen et al. (2009) investigated users of oral 
estradiol replacement therapy and controls (nonusers), and found that collagen turnover in the 
resting state, and collagen responses to exercise were negatively associated with s-estradiol. 
Therefore, in Paper I we wanted to investigate whether male had higher risk of developing 
jumper’s knee compared to females in a cohort of adolescent athletes. 
 -XPSLQJDELOLW\
Jumping plays an essential role in volleyball; key skills like spiking, blocking, serving and 
even setting involve jumping. These jumps are often maximal and, depending on their playing 
position, athletes could jump up to 300 times during a 5-game match (Hasegawa et al. 2002; 
Forthomme et al. 2005; Sheppard et al. 2007). Middle blockers tend to suffer from jumper’s 
knee more than players in other positions (Bahr and Reeser 2003). Jumping ability is an 
important criterion when selecting players. Studies show that players on a high level have 
higher vertical jump height compared to players at lower levels (Smith et al. 1992; Hasegawa 
et al. 2002). Forthomme et al. (2005) examined 19 male volleyball players from the two 
highest Belgian national divisions, and they underwent a jumping capacity test. They also 
compared first-division and second-division player data and found that counter movement 
jump (CMJ) was 10% higher among male first division than second division players. The first 
division players were older and trained more “muscular” training per week. Such differences 
could be a consequence of not just selection and genetics, but also training could obviously 
make a difference. Lian et al. (1996) had 12 athletes with jumper’s knee and 12 controls 
selected from a population of 141 well-trained male Norwegian volleyball players, of which 
55 (39%) satisfied the diagnostic criteria for jumper's knee. Their testing program consisted of 
different types of jumps: standing jump (SJ), CMJ, 5-second rebound jump test, standing 
jump with a 20-kg load, and standing jump with a load corresponding to one-half of the 
subject's body weight. The test results of the patient group were significantly higher than 
those of the control group for the countermovement jump (15% increase), power during 
rebound jump (41%), work done in standing jump (12%) and countermovement jump (22%), 
and the difference between countermovement jump and standing jump (effect of adding 
eccentric component). Thus, in this case-control study athletes with jumper's knee 
demonstrated better performance in jump tests than uninjured athletes, particularly in ballistic 
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jumps involving eccentric force generation. Lian et al. (2003) did a similar study among 47 
elite volleyball players where 24 (51.0%) were diagnosed with current jumper’s knee. They 
used the same jump tests but were unable to reproduce the same results as in 1996. Still, they 
concluded that the results from the jump-testing program showed an increased overall 
performance ability of the leg extensors among players with a current diagnosis of jumper’s 
knee compared with players without a history of jumper’s knee. In contrast, Malliaras et al. 
(2006) found no differences in jump height in a cross-sectional study of 113 participants in 
athletes between the three outcome groups; athletes with pain and image abnormal, no pain 
and image abnormal and no pain and image normal. Tendons with pain and normal imaging 
were excluded.  
The jumper’s knee paradox, where symptomatic athletes in case-control studies seems to have 
performed substantially better in a counter movement jump compared to asymptomatic 
controls has never been explained properly. We do not know if athletes who naturally jump 
well have a higher risk of developing jumper’s knee or if their jumping skills are the result of 
higher training loads. Therefore, this issue was investigated in Paper II. 
 8OWUDVRXQGFKDQJHV
As previously described, most tendons with symptoms of jumper’s knee do reveal 
pathological abnormalities when examined by ultrasound. However, the relationship between 
structural tendon changes and pain remains to be fully elucidated. Present knowledge is not 
clear on whether the presence of ultrasound changes in asymptomatic tendons precedes (and 
predicts) future tendon problems. Previous longitudinal studies on the patellar tendon have 
yielded conflicting evidence. Cook et al. (2000) followed 26 young asymptomatic basketball 
players (14-18 yrs) for 16 months. At baseline, 10 of 52 patellar tendons had hypoechoic 
areas and 3 of them went on to develop jumper’s knee compared to 3 of the 42 normal 
tendons. The authors concluded that a hypoechoic area represented a risk factor for 
developing jumper’s knee, but also that structural changes were not necessarily associated 
with symptoms. However, the same research group also followed 23 asymptomatic football, 
basketball and cricket players (age: 30 yrs) for 4 years (Cook et al. 2001). In this small 
prospective study on adult athletes, ultrasound changes did not predict future tendon 
problems. At baseline, 18 of 46 tendons had hypoechoic changes. During the 4-yr study 
period, 6 tendons developed clinical symptoms; of these, 4 had hypoechoic changes at 
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baseline and 2 were normal. Fredberg & Bolvig (2002) followed 54 adult professional soccer 
players for one season. They concluded that hypoechoic regions were associated with 
development of symptoms, even if only 3 of 18 with hypoechoic areas at baseline became 
symptomatic. Notably, 9 tendons were still hypoechoic but asymptomatic and 6 tendons 
normalized. Also, 6 normal tendons developed hypoechoic areas but no symptoms after 11 
months. 
Hypoechoic changes are observed in 10-30% of asymptomatic tendons, and hypoechoic areas 
can resolve, remain unchanged, or expand (Lian et al. 1996; Khan et al. 1997; Cook et al. 
2000; Fredberg and Bolvig 2002). It can be hypothesized that the presence of ultrasound 
findings in the tendon may increase the risk of developing tendon pain. This effect may be 
somewhat more pronounced in younger athletes than among adults. Paper III aimed to 
investigate the relationship between the development of ultrasound changes in the patellar and 
quadriceps tendons and symptoms of jumper’s knee.  
 *HQHWLFV
Involvement of genetics in tendon injury was originally proposed because of an association 
between the blood group O and Achilles tendon ruptures or chronic Achilles tendinopathy 
evident in Hungarian and Finnish populations (Jozsa et al. 1989; Kujala et al. 1992; Kannus 
and Natri 1997). The gene for ABO on chromosome 9q34 encode for transferases which, 
apart from determining the structure of glycoprotein antigens on red blood cells, may also 
determine the structure of some proteins of the extracellular matrix of tendons (Jozsa et al. 
1989). Sequence variants within genes that encode for several tendon and/or ligament 
extracellular matrix proteins have been shown to be associated with specific musculoskeletal 
soft tissues injuries (Mokone et al. 2005; Mokone et al. 2006; Collins and Raleigh 2009). 
Variants within the TNC, COL5A1 and MMP3 genes co-segregate with chronic Achilles 
tendinopathy. The variant within the TNC gene also appears to co-segregate with Achilles 
tendon ruptures, while sequence variants within the COL1A1 and COL5A1 genes have been 
shown to be associated with cruciate ligament ruptures and/or shoulder dislocations. The 
COL5A1 gene, which is in close proximity to the ABO genes on chromosome 9q34 (Caridi et 
al. 1992), encodes for a structural component of type V collagen which forms heterotypic 
fibres with type I collagen in tendons and possibly plays an important role in regulating 
fibrillogenesis and, therefore, tendon strength (Silver et al. 2003; Riley 2004). Still it is 
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unclear whether or not COL5A1 and TNC genes are the ideal markers of tendinopathy 
(Magra and Maffulli 2008). The relationship between genetics and tendinopathy has mainly 
been investigated in Achilles tendon but also in studies in supraspinatus tendon, anterior 
cruciate ligament (ACL) rupture, superficial digital flexor and posterior tibial tendon. The 
role of these genes in the pathogenesis of tendinopathy needs further investigation, as does 
their association with patellar tendinopathy. 
 $QWKURSRPHWU\DQGELRPHFKDQLFV
Several studies have investigated the association between leg-length differences and jumper’s 
knee. Kujala et al. (1986) reported a larger leg-length difference in subjects with jumper’s 
knee in a case-control study with 20 patients with patellar “apicitis” (jumper's knee) and 20 
controls. The study of Witvrouw et al. (2001), however, found no association with leg-length 
difference in their cohort between the 19 athletes developing jumper’s knee compared to 119 
that remained asymptomatic after having been followed for two years. A longer tibia length 
relative to stature was found by Gaida et al. (2004) in subjects with unilateral jumper’s knee. 
Kujala et al. (1986) found no difference between controls and subjects with jumper’s knee in 
Q-angle displacement during knee flexion. Similar results were found by Witvrouw et al. 
(2001) with no difference in Q-angle at rest and no difference in the medial tibial 
intercondylar distance. One study that investigated the arm span to height ratio found no 
association between this ratio and jumper’s knee (Cook et al. 2004). Malliaras et al. (2006) 
examined 113 competitive volleyball players in a cross-sectional study. They concluded that 
there was areduced range of ankle dorsiflexion in the jumper’s knee group. Having less than 
45° of ankle dorsiflexion range increased the risk of patellar tendinopathy by 1.8 to 2.8 times. 
Schmid et al. (2002) investigated 19 patients from an orthopedic clinic with jumper’s knee 
with 32 asymptomatic controls. They found no differences between the groups regarding 
patellar impingement when examined with dynamic MRI. The biomechanical aspects of 
jumping and landing have not been investigated properly. There are some indications that 
large external tibial torsional moments combined with deep knee flexion angles during a jump 
and landing increases the risk of jumper’s knee (Richards et al. 2002). These results are from 
a small cross-sectional study of 10 members of the Canadian Men's National Volleyball Team 
where 3 of the 10 players had jumper’s knee at the time of the study. Landing surface may be 
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important and beach volleyball players have a lower prevalence of jumper’s knee compared to 
indoor volleyball players (Ferretti et al. 1984; Bahr and Reeser 2003). 
1.6 Aim of the thesis 
Based on this literature review the aims of this thesis were: 
1. To investigate total training and competition load as risk factors for developing
jumper’s knee (Paper ȱ).
2. To investigate whether body composition or change of body composition represents a
risk factor for developing jumper’s knee (Paper ȱ).
3. To investigate jumping ability and change of jumping ability as risk factors for
developing jumper’s knee (Paper ɉ).
4. To investigate the relationship between the development of ultrasound changes in the
patellar and quadriceps tendons and symptoms of jumper’s knee (Paper III).
5. To examine the medium-term effects of intensive training on tendon thickness among
adolescent athletes (Paper ɒ).
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 0HWKRGV
2.1 Study design 
Paper ȱ- ɒ were based on a prospective cohort study with a total data collection period of 5 
years. All participants were recruited from the same cohort, but the time and duration of 
inclusion were differed between participants. Data collection for Paper ȱ & ɉ started year 1 
(2006) while data collection for Paper ɒ started year 2 (2007).  
2.2 Patient recruitment 
All participants (Paper ȱ-ɒ) were recruited among players entering the Toppvolley Norway 
(TVN) program. TVN is located in Sand, Norway and combines an elite volleyball training 
program with a three-year senior high school boarding school program. The students started 
at the age of 15-16 years, and they were expected to complete three years for a college-entry 
baccalaureate degree. Some students entered the program in the second or third school year. 
TVN aimed to recruit the most talented junior volleyball players in Norway, and the athletes 
represented the school in the Norwegian national leagues at various levels. However, players 
could also play tournaments and league matches for their home clubs. Many of the players 
also qualified for different junior national team programs. 
The recruitment process began when school started every autumn with an information 
meeting. Potential participants were also informed in writing before their written consent was 
obtained, and also that of their parents if the athlete was younger than 18 years old. The 
flowcharts from Paper ȱ-ɒ, depicting how participants entered and left the study are not 
identical. In Paper II some students could not be included because no data were recorded and 
some could not be included because a technical problem caused loss of data from testing 
during year 2.  
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2.3 Inclusion criteria 
All students at TVN were eligible for this study. In Paper ȱ & ɉ only athletes without 
jumper’s knee at baseline were included, while Paper ɒ also included athletes with pre-
existing jumper’s knee.  
2.4 Diagnosis 
Jumper’s knee is a clinical diagnosis. The following diagnostic criteria were used (Lian et al. 
1996; Lian et al. 1996; Lian et al. 2003; Lian et al. 2005; Visnes et al. 2005; Hoksrud et al. 
2008):  
1. A history of pain in the quadriceps or patellar tendons at their patellar insertions in
connection with training or competition
2. Tenderness to palpation corresponding to the painful area.
3. Symptoms had been present for a minimum of 12 weeks.
 In addition, all symptomatic athletes underwent a standard knee examination to exclude other 
diagnoses like patellofemoral pain syndrome, inflammatory joint conditions, or degenerative 
conditions.  
2.5 Patient evaluation 
 9,6$VFRUH
Knee function was self-reported using VISA score (Paper II & III). 
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2.6 Body composition 
Body composition was assessed by measuring height and weight, waist circumference and 
through skin fold caliper tests. Waist circumference (nearest mm) was measured with 
anthropometric tape around the umbilicus at the end of a normal expiration (Steene-
Johannessen et al. 2010). Four skinfold thickness measurements (triceps, biceps, subscapular 
and suprailiac) were taken using a Harpenden skinfold caliper (John Bull, British Indicators 
Ltd., West Sussex, England) on the non-dominant side of the body according to the criteria 
described by Lohman et al. (Lohman et al. 1991). These examinations were repeated twice a 
year as long as participants remained in the cohort, and were presented in Paper I.  
2.7 Training volume & match exposure 
Training volume was recorded prospectively on a weekly basis (Paper I-III). We organized 
the registration on an individual basis through a web-based weekly training diary, with six 
questions about the number of hours of volleyball, beach volleyball, strength, jump training 
and other training. The number of sets played in matches during the last week were also 
recorded. An individual registration was necessary because not all training was organized and 
the athletes played matches for their home clubs and junior national teams, as well. In case 
data were incomplete, we interviewed the player and their coach to estimate exposure as 
precisely as possible. In Paper ɉ-ɒ. match exposure were not recorded. We only collected 
data during the 10-month school year. Information was also collected about their previous 
training volume in volleyball, strength training and other training during the last year before 
attending TVN.  
43 
2.8 Jump test (Paper II) 
Two types of jumps were tested. Both SJ and CMJ are tests commonly used for testing elite 
athletes in different sports in Norway. SJ were performed with the subject starting from a 
stationary semisquatting position with 90° of knee flexion and with both hands kept fixed on 
the hips. No counter movement was allowed with any body segment and the computer 
measured these movements and did not accept such attempts. In the CMJ the subject started 
the movement from a stationary erect position with knees fully extended, and was allowed to 
bend down to approximately 90° of knee flexion before starting the upward motion of the 
jump. This jump is a ballistic movement with rapid eccentric muscle action immediately 
followed by a maximal concentric contraction. Both hands were kept fixed on the hips.(Lian 
et al. 2003) The best out of three technically correct jumps was used for the final 
calculations. 
Figure 7.  Starting position for a CMJ and SJ.  
Jump tests were done on a portable force plate (Musclelab 4000, Ergotest Innovation a.s., 
Porsgrunn, Norway) to estimate vertical jump height. The portable force plate has 
demonstrated to be a valid measure of vertical jumping ability (Buckthorpe et al. 2012). 
These tests were performed two times per year, first at the start of the school year (August/
September) and then 6 months later at the end of the volleyball season (March/April). 
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2.9 Ultrasound examination (Paper III) 
An ultrasound examination were done within the first weeks and then again every 6 months 
for as long as students remained at TVN. An experienced orthopaedic surgeon with extensive 
musculoskeletal ultrasound training (AT), who was blinded to the clinical history carried out 
all ultrasound examinations during 4 year of the study period. Two ultrasound machines with 
similar specifications were used for all examinations over the study period (GE Logiq e, 12L-
RS probe and GE Logic Book XP, 12L-RS probe, GE Vingmed ultrasound AS, Horten, 
Norway). Recent studies have shown that intratendinous flow can be increased during 
exercise (Malliaras et al. 2008; Koenig et al. 2010), and none of the athletes came straight 
from training, but we did not collect information about their activity during the previous 24 
hours. Ultrasound examination of both the patellar and quadriceps tendon was carried out 
with the patient supine, with the knee in slight flexion (20°). The quadriceps muscles were 
relaxed to avoid underestimating color Doppler flow (Koenig et al. 2007). Tendon thickness 
was measured in the proximal, middle and distal part of the tendon. Any pathologic changes 
in the tendons were registered on a standard form. All clearly defined hypoechoic areas seen 
in both longitudinal and transverse ultrasound scans were registered as pathologic, regardless 
of the size of the area.  Color Doppler was used to diagnose increased blood flow within the 
tendon, which has been termed neovascularisation(Öhberg et al. 2001). The color Doppler 
gain was set just below the level that produced random noise in the image (Boesen et al. 
2012), and the Doppler settings were the same for all examinations. To our knowledge, no 
technology existed to reliably quantify flow in the tendon when the study started. Therefore, 
we used the same semiquantitative method that has been used in previous studies (no flow = 
0; flow outside the tendon = 1; one or two vessels inside the tendon = 2; and multiple vessels 
inside the tendon = 3) (Hoksrud et al. 2006; Gisslen et al. 2007). For subsequent data analyses, 
we defined neovascularisation as the presence of vessels inside the tendon (2 and 3).  
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Figure 8. Ultrasound examination in 
athletes 
2.10 Statistics 
In Paper ȱ-ɒ: Training volume was calculated as the mean number of hours per week and 
match exposure as the mean number of sets per week for the period included. All potential 
risk factors were compared using unpaired t-tests examined in univariate analyses and those 
with a P-value <0.20 were investigated further in a multivariate regression model. Different 
logistic regression models were run to compare the strengths of association between injury 
and exposure of training and matches. Model prognostic indexes were also used to compare 
predictive ability between the different models by receiver operating characteristic analysis. 
In the multivariate analyses, we have combined data on present and previous training and 
match exposure with gender; but because of limitations in statistical power, we could only 
include two or three factors at the time. Also, as there was a strong correlation between total 
training volume and the other training forms, these factors could not be included in the same 
model. Odds ratio (OR) are reported with 95% confidence limits and P-values of <0.05 were 
considered statistically significant..  
In Paper II: The results from the jump tests are presented as the height of rise of the center of 
gravity (in cm), and we calculated the change in jump height the same way for asymptomatic 
and symptomatic athletes in two ways: 1) From baseline until 6 months after enrolment, and 
2) from baseline to graduation. Odds ratios for increased risk of jumper’s knee are reported
per cm difference in jump test results. We report Pearson coefficients for the correlation 
between training volume and change in jumping ability. 
In Paper ɒ: Changes in tendon thickness per site were analysed using paired t-tests. Since 
right and left tendons are coupled and not independent, a global multivariable linear model 
(GLM) on both sides and for the proximal, midportion and distal part of the tendon was fitted 
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to test the hypothesis that all changes in the tendon variables were equal to zero 
simultaneously. This test creates a vector of changes per tendon where change in 
measurements from proximal, mid and distal were three components in the vector account the 
within-person correlation of the components in the vector. This was done by the Wilks-
Lambda method. Analyses were adjusted for gender. Similarly, total changes in tendon 
thickness were also tested against zero using the same method. The multivariable gender 
differences in changes (of tendon variables) were tested by Hotelling’s T-squared statistics. 
Associations between training volume and changes in tendon thickness were assessed by 
multiple linear regression analyses. Odds ratios for hypoechoic areas and neovascularisation 
at baseline were analyzed with a logistic regression analysis model adjusted for gender.  
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 5HVXOWVDQG'LVFXVVLRQ
3.1 Recruitment and patient characteristics 
 5HVXOWV
Altogether, 192 students were registered in the school record at TVN during the 5-year study 
period, but some left school before they could be informed about and included in the study. 
Paper I and II are based on data collection from 2006, while data collection for Paper III 
started in 2007. In table 5, the three cohorts included in Papers I-III are summarized. 
Table 5. Description of the inclusion and follow-up of subjects during the 5-year study period. 
Paper I Paper  II Paper III 
Study period 4 yrs 5 yrs 4 yrs 
Total number of 
athletes in school 
164 189 158
Athletes included 141 (69m/72f) 150 (68m/82f) 158 (84m/74f) 
Mean observation 
period (years) 
1.8±0.8 1.7±0.8 1.7±0.7
Developed jumper’s 
knee (#) 
28 (22m/6f) 28 (22m/6f) 22 (18m/4f) 
(35 tendons) 
Time until diagnosis 
(years) 
0.9  0.8  0.9 
In most cases, their symptoms stemmed from the proximal patellar tendon (n=25); only 3 
cases (2 males/1 female) were located in the distal quadriceps tendon (Paper I-II). The data 
and the athletes included in Paper I and II are similar but not identical (Paper I: years 1-4, 
Paper II: years 2-5). A total of 17 of 158 students (6 females, 11 males) had pre-existing 
jumper’s knee when enrolling at TVN (Paper III). In most of these cases (n=14, 19 tendons), 
their symptoms stemmed from the proximal patellar tendon, while in 3 cases (1 female, 2 
males, 4 tendons) symptoms were from the distal quadriceps tendon. Of the 22 athletes with 
new problems, all had symptoms from the proximal patellar tendon, and 13 (3 females, 10 
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males) developed bilateral symptoms. Therefore, a total of 35 tendons developed jumper’s 
knee. 
3URJQRVLV3DSHU,,,
A total of 39 athletes with jumper’s knee (22 new cases of jumper’s knee and 17 with pre-
existing symptoms) were followed for an average of 1.0 (SD 0.7) year and with 2.0 (SD 1.4) 
ultrasound examinations after diagnosis. They reported a VISA score of 72 (SD 23) when first 
diagnosed, which did not change during subsequent examinations and was 73 (SD 21) when 
they left TVN.
 'LVFXVVLRQ
Nearly one in three boys (32%) developed jumper’s knee during their time at TVN (Paper I). 
Since only one out of 28 cases in Paper I debuted during the final year it seems as if a player 
is able to tolerate the high volume of training and matches the first 1-2 year, the risk of 
developing jumper’s knee is much lower and that the at-risk players have been affected by the 
condition by then. However, we do not know if the asymptomatic group represented a more 
resistant group of players that will also avoid developing symptoms later in their career. 
Starting at TVN represents a high-risk situation for promising players and adolescents athletes 
may have more pronounced risk compared to adults. Cook et al. (1997) found that 56% of 100 
athletes with jumper’s knee had developed symptoms before the age of 20.  
Prevalence is previously described around 40-50% among adult male volleyball players (Lian 
et al. 1996; Lian et al. 1996) while among elite junior volleyball players prevalence has been 
reported as 14% (Gisslen et al. 2005). In Paper III, the prevalence of jumper’s knee among 
athletes leaving TVN was 25% (male 39%, female 8%). Thus, unfortunately males graduating 
from TVN have a prevalence of jumper’s knee similar to that as previous found among adult 
elite volleyball players in Norway.  
The jumper’s knee diagnosis was based on clinical examination alone. Jumper’s knee is a 
difficult diagnosis, but patellar tendon palpation is a reliable examination for a single 
examiner (Cook et al. 2001). Imaging like ultrasound or MRI was not required to make the 
diagnosis, and at the time of diagnosis 6 of 35 had no ultrasound findings like hypoechoic 
areas and neovascularisation. These results are similar to previous studies, and it is therefore 
important to note that a study population based on a clinical diagnosis of jumper’s knee 
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compared to patellar tendinopathy verified by ultrasound or MRI, would not include the same 
patients (Warden et al. 2007; Hoksrud et al. 2008). 
The proximal patellar tendon was the dominant location of symptoms (92%) compared to the 
distal quadriceps tendon (8%). The majority of the athletes in this cohort had bilateral 
symptoms. Lian et al. (2005) found that 37 of 87 athletes with current symptoms had bilateral 
symptoms, and these are similar to findings in Paper III where 13 of 22 had bilateral 
symptoms. Development of jumper’s knee seems to be a bilateral process where both tendons 
are affected.  
3URJQRVLV
The athletes were followed as long as they were students at TVN. We did not record 
treatment systematically. The general principles organized by school physiotherapist were 
reduced tendon load (less volleyball and less jumping), alternative training (swimming), 
training treatment (eccentric training or heavy slow resistance training) and shock wave 
therapy. Despite this symptoms remained the same during the observation period. Even 
though some athletes are able to participate in sport despite their problems, a cross-sectional 
study where  athletes who had attended a sports medicine clinic were recruited, found that 
33% of the 100 athletes had been kept out of sport for over six months because of symptoms 
of jumper's knee (Cook et al. 1997). The medium or long-term consequences of jumper’s knee 
is poorly characterized; athletes may have retired early, some may have settled for a career on 
a lower level of performance because they could not tolerate the heavy training and 
competition load at the elite level. Kettunen et al. (2002) followed 36 athletes from a previous 
case–control study for 15 years. They found that as many as 53% of athletes with jumper’s 
knee were forced into retirement. However, 15 years later jumper’s knee caused mild during 
daily activities. However, there was no difference in work ability or current leisure time 
physical activity between the athletes with or without previous jumper’s. This study included 
no data about reduced training volume, reduced training intensity or how many of the athletes 
left school because of the jumper’s knee.  
Treating these athletes is challenging and the best treatment regime is unknown. However, 
our data suggest that the prognosis is poor for complete rehabilitation of young athletes with 
jumper's knee as long as they remain students at an elite sport school.  
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3.2 Training volume & match exposure 
 5HVXOWV
Athletes developing jumper’s knee had higher total training volume and tendon load 
compared to those who remained asymptomatic. A significant differences was observed for 
indoor volleyball training (jumper’s knee: 14.9±2.8 h/week vs asymptomatic athletes: 
12.0±3.7 h/week, p=0.001), while we did not see any differences for beach volleyball 
training, strength training or other training. The number of sets played in matches was also 
higher in the jumper's knee group. These trends were similar for males and females. Previous 
training history was recorded and the jumper’s knee group did significantly more volleyball 
training (10.5±6.2 h/week) before entering the TVN program compared to the asymptomatic 
group (7.6±4.6, p=0.01). We found no difference in previous strength training, while the 
asymptomatic group did more training in other sports (1.5 ± 2.2 h/week) compared to the 
jumper’s knee group (0.5±0.9 h/week, p=0.03). In a multivariate regression analysis, 
corrected for gender, the analyses showed that match exposure was the strongest sports-
related predictor for developing jumper’s knee with an OR of 3.88 (95% CI 1.80 to 8.40) for 
every extra set played per week. Volleyball training had an OR 1.72, (95% CI 1.18 to 2.53) 
when combined with match exposure and gender. As we only had information about previous 
training volume in 124 out of 141 athletes, this factor had to be analyzed separately. We 
found that a high volume of previous volleyball training increased the risk of jumper’s knee 
(OR 2.22 per hour of training, 95% CI 1.20 to 4.11).  
 'LVFXVVLRQ
This is the first prospective cohort study to identify volume of training and match exposure as 
risk factors for jumper’s knee. Volleyball training accounted for nearly all of the difference 
between the group that developed jumper’s knee and the group that remained asymptomatic. 
As the daily volleyball training schedule on weekdays was organized by the school, these 
group differences were somewhat surprising. However, a closer look at the data revealed that 
some athletes in periods could train up to 30 h per week in different training camps with 
national teams or home clubs compared to those who went home to their families to relax. 
Based on the literature, athletes that increased their training volume the most were also 
expected to have the highest risk (Lian et al. 2003; Reeser et al. 2006). It was therefore 
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surprising that the jumper’s knee group had trained significantly more volleyball the year 
before they started at TVN, about 3 h more per week. Since both groups increased their 
volume with approximately 5 h more volleyball per week, an increase of 42% for the 
jumper’s knee group and 66% for the asymptomatic players were found. These numbers 
indicate that the total volume of training over a period is maybe as more important as the 
relative increase in training exposure from one year to the next. If the risk of jumper’s knee 
increasing linearly in response to load, or if there is a threshold volume of training where the 
risk increases more, needs further study.  
Match exposure, i.e. the number of sets played per week, was the strongest sports-related 
predictor for developing jumper’s knee in the multivariate analysis. These athletes played 
matches for their home clubs as well as the school teams, and many of the league matches are 
organized as weekend tournaments. An obvious explanation may be that the players affected 
are the best players, and the player and their school, club and national team coach had the 
same interest in their playing as much as possible, without much thought of the consequences 
for injury. 
Early sport specialization is a contentious issue. One question is whether varied sports 
participation during adolescence can protect against overuse injuries. Repetitive volleyball-
specific training alone could overload the patellar tendon, in contrast to a more varied training 
program which includes other sports. Our data show that athletes and especially boys in the 
jumper’s knee group hardly played any other sports during the final year before joining the 
intensive volleyball program at TVN. The group that remained healthy previously had trained 
more in other sport like football, handball or skiing. However, these numbers were small and 
should be interpreted with caution.   
3.3 Body composition (Paper I) 
 5HVXOWV
We did not detect any significant differences in body composition at the time of inclusion or 
change of body composition during the study period between players who developed jumper's 
knee and those who did not developed jumper’s knee.  
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 'LVFXVVLRQ
It is important to note that the volleyball players studied represent a selected group of 
relatively tall and lean athletes, and therefore not comparable with previous studies, showing 
a correlation between tendinopathy and body composition in the general population 
(Wendelboe et al., 2004; Werner et al., 2005). A systematic review on the relationship 
between adiposity and tendinopathy (Gaida et al. 2009) identified only one study among 
young athletes (Cook et al., 2004). This cross-sectional study among elite junior basketball 
players found no differences in height, weight, or skinfold thickness between players with 
ultrasound abnormalities and players with normal tendons (Cook et al., 2004). Lian et al. 
identified body mass as a risk factor in two previous studies (Lian et al. 1996; Lian et al. 
2003). In these studies there was no data on body composition, but the participants were 
described as well trained athletes. Crossley et al. (2007) found that a higher body mass index 
(BMI) was associated with jumper’s knee. This finding concurs with a study by Malliaras et 
al. (2006), who also found an association between a higher BMI and jumper’s knee, albeit 
only in men. Waist girth and hip girth were associated with jumper’s knee in men in one 
study (hip girth only in men with bilateral jumper’s knee) (Malliaras et al. 2007), but not in 
another study that only included women (Gaida et al. 2004). In a study among basketball 
players, hip-waist ratio had the highest odd ratio (21.6) for jumper’s knee (van der Worp et al. 
2012). Higher body mass could cause higher load on the patellar tendon. However, several 
studies have not identified body mass as a risk factor (Kujala et al. 1986; Lian et al. 1996; 
Witvrouw et al. 2001; Cook et al. 2004; Gaida et al. 2004). In other words, there is no 
evidence for a link between body composition and the risk or jumper’s knee among young, 
well-trained athletes. 
3.4 Gender (Paper I) 
 5HVXOWV
Males had three to four times higher risk for developing jumper’s knee compared to females, 
independent of training and match exposure in a multivariate regression analysis. Nearly one 
in three boys developed jumper’s knee during their time at TVN (32%) compared to only 8% 
of the girls. 
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Three to four times higher risk for men is somewhat higher compared to previous cross-sectional 
studies (Lian et al. 2005; Zwerver et al. 2011; van der Worp et al. 2012). Lian et al. (2005) found 
the prevalence of current symptoms of jumper’s knee was lower among women in team handball 
and soccer with 5.6 % compared to a combined prevalence of 13.5 % in the corresponding male 
sports. Van der Worp et al. (2012) invited all basketball and volleyball players in the Netherlands 
to an online survey and found among the 2363 responded that males had around 2 times higher 
risk compared to females. Zwerver et al. (2011) interviewed 891 male and female nonelite athletes 
from 7 popular sports in the Netherlands, and male athletes had a significantly higher prevalence 
(10.2%) than in female athletes (6.4%). This gender difference may be caused by the difference in 
the force-generating capacity of the quadriceps between men and women. The gender effect 
seems more pronounced in volleyball, probably because the sport includes a lot of jumping. It is 
well documented that the jumping ability and force-generating capacity is lower among women 
than men (Lian 2006). So, even if the number of jumps may be similar between men and women 
playing the same sports, the lower prevalence may simply reflect that the forces that are 
transmitted through the quadriceps and patellar tendons are lower among women. Janssen et al. 
(2014) investigated landing technique and patellar tendon loading of 20 male and 20 female 
volleyball players performing a lateral stop-jump block movement. Male volleyball players were 
taller and heavier, landed from a higher height, displayed differences in landing kinematics, 
generated a significantly greater knee extensor moment, and experienced higher patellar tendon 
loading than female players. However, when participants were matched on jump height, they 
generated similar patellar tendon loading, irrespective of their sex. They conclude that jump 
height is a more important determinant of patellar tendon loading than sex. On the other hand, the 
CSA of the tendon is smaller in women, and since tendon stress describes the tendon force relative to 
the tendon CSA, the mechanisms underpinning the gender difference observed are not fully 
understood.  
3.5 Jumping ability (Paper II)  
 5HVXOWV
At the time of inclusion, healthy male athletes who went on to develop jumper’s knee had 
significantly better results in CMJ (38.0±5.8 cm vs 34.6±5.5 cm) compared to asymptomatic 
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males, while no difference was detected in SJ (30.3±7.4 cm vs 28.1±6.1).  Among females, 
there was no difference in SJ (jumper’s knee: 22.1±3.2 cm vs healthy: 21.7±4.6 cm) or CMJ 
(jumper’s knee: 27.2±5.4 cm vs healthy: 24.8±4.6 cm) at inclusion. In a multivariate logistic 
regression analysis corrected for gender and previous volleyball training, the OR for 
developing jumper’s knee was 2.09 (95% CI 1.03 to 4.25) per cm difference in CMJ at the 
time of inclusion.  
No difference in the change in jumping ability between the jumper’s knee group and healthy 
group were detected. Compared to baseline, healthy males and females improved their 
jumping ability in both tests after 6 months and at the end of their period at TVN. In the 
jumper’s knee group, only males improved their CMJ results compared to baseline, while 
females did not improve.  
Among athletes that remained healthy there was a weak correlation between the volume of 
volleyball training and change in jumping ability for CMJ from baseline until their last test at 
TVN (r2=0.15, p<0.001). We found no correlation for SJ (final test) in this group, nor was 
there any correlation between training volume and change in jumping ability in the group of 
athletes who developed jumper’s knee. 
 'LVFXVVLRQ
The jumper’s knee paradox, where symptomatic athletes appear to perform better in a CMJ 
compared to asymptomatic controls in previous case-control studies, is poorly understood.  
This is the first prospective cohort study available, where jump performance was assessed 
before players developed symptoms of jumper’s knee, documenting an association between 
the jumping ability and the risk for developing jumper’s knee. An obvious explanation for this 
finding could be that players who jump well subject their tendons to higher load and therefore 
have higher risk. We only found this difference in the dynamic CMJ test, not in the more 
static SJ. It may be that these athletes are better at utilizing the eccentric prestretch component 
of the ballistic motion to increase their jumping height. It seems reasonable to suggest that 
their talent for jumping high, which results in higher tendon strain, amplifies the risk of 
tendon problems when subjected to an intensive program of training and competition such as 
that at TVN. 
Another hypothesis was that not only baseline jumping ability, but also the rate of 
improvement in jumping ability could be a risk factor, i.e. that players who increase their 
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jumping ability rapidly would be at higher risk because their capacity for loading the tendon 
is not matched by a simultaneous improvement in tendon properties. Our results did not 
reveal any significant differences in the change in jumping ability between the group that 
developed jumper’s knee and those who remained asymptomatic, although both groups 
improved their CMJ performance. The athletes developing jumper’s knee increased their 
jumping performance continuously despite having developed symptoms. The exception was 
the few girls that developed jumper’s knee, who decreased their jumping performance for 
CMJ. There is no obvious reason for girls to be more limited by pain and the numbers are 
small.  
The main findings in Paper II support the hypothesis that there is an association between the 
talent for jumping high and the risk for developing jumper’s knee. This sheds light on the 
jumper’s knee paradox where athletes with tendon pain have performed substantially better in 
jump tests compared to asymptomatic controls. Our data support the theory that jumping 
ability is not affected by the pain associated with jumper’s knee.  
3.6 Ultrasound: Relationship between structural changes 
and symptoms (Paper III)
 5HVXOWV
About half of the asymptomatic athletes who went on to develop jumper’s knee (17 of 35 
tendons) had hypoechoic areas when they started at TVN, while 10% of the tendons that 
remained asymptomatic (24 of 238 tendons) had the same changes. Neovascularisation was 
found in 4% (9 of 238 tendons) of asymptomatic tendons and in 48% (15 of 35 tendons) of 
those who later developed jumper’s knee. In a multivariate logistic regression analysis, a 
baseline finding of a hypoechoic tendon area (OR 3.3, 95% CI 1.1 to 9.2) and 
neovascularisation (OR 2.7, 95% CI 1.1 to 6.5) increased the risk of developing jumper’s 
knee. At the time when the clinical diagnosis of jumper’s knee had been made, 83% (29 of 35 
tendons) of the tendons revealed hypoechoic areas and 74% (26 of 35 tendons) 
neovascularisation. The prevalence of ultrasound changes among the athletes who developed 
jumper’s knee remained the same from the time of diagnosis until they left school. The 
asymptomatic tendons had the same prevalence during the whole study period (hypoechoic: 
10%, neovascularisation: 3-4%).  
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In asymptomatic quadriceps tendons, the prevalence of hypoechoic areas (4-7 %) and 
neovascularisation (3-4%) was lower compared to asymptomatic patellar tendons. 
 'LVFXVVLRQ
Our study, which is one of the largest to date on the patellar tendon, shows that the presence 
of hypoechoic areas and neovascularisation among asymptomatic athletes at baseline 
represented a risk factor for developing tendon pain. In the same time period as this study, 
others have investigated the same issue. Gisslén et al. (2007) monitored a population 
comparable to TVN, 22 adolescent volleyball players (16 yrs at inclusion), for 3 years. Of the 
36 tendons which were asymptomatic at baseline, 3 of 9 with structural changes did develop 
symptoms, while only 2 of the 27 structurally normal tendons later developed jumper’s knee. 
Fredberg et al. (2008) randomized 209 professional soccer players to either a control group or 
to an intervention group who was given a prophylactic eccentric training program for the 
Achilles and patellar tendons during one soccer season. At inclusion 28% had “severely 
abnormal” patellar tendons. They found that players had a relative risk of 2.2 (P=.09) for 
developing symptoms during the season if severe ultrasonographic abnormalities in the 
patellar tendons were detected before the start of the season. Two more recent studies have 
also identified ultrasound changes as a risk factor (Comin et al. 2013; Giombini et al. 2013). 
Comin et al. (2013) surveyed 79 professional ballet dancers (158 patellar tendons) in a 24-
month longitudinal study. A total of 7 tendons developed disabling symptoms, 3 of these were 
among the 19 which  had hypoechoic changes at baseline and only 4 of 139 with normal 
tendons developed symptoms. Giombini et al. (2013) followed 37 elite fencers training for the 
Olympics (age: 27 yrs) for 36 months. Since 2 of 8 tendons with abnormal ultrasound findings 
at baseline developed symptoms and none of 66 normal tendons did, they concluded that 
ultrasound imaging may be predictive for development of future symptoms in patients with 
patellar tendinopathy.  
Whether color Doppler may contribute additional information to grey-scale ultrasound is 
unknown. Boesen et al. (2012) used color Doppler in their study among semi-professional 
badminton players. They concluded that intratendinous blood flow did not predict injury and 
that the level of intratendinous blood flow more likely represents a physiological response. 
Some studies have also shown that there is some degree of color Doppler activity in the 
healthy tendon after exercise (Boesen et al. 2006; Malliaras et al. 2008; Koenig et al. 2010) 
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and so far the role of these blood vessels in a painful tendon is unknown. It remains an 
important research question to distinguish between possible physiological intratendinous flow 
and possible pathological activity (Koenig et al. 2010). 
The prevalence of hypoechoic areas is lower in asymptomatic quadriceps tendons compared 
to patellar tendons. Giombini et al. (2013) found abnormalities in 3 (4%) of 74 asymptomatic 
quadriceps tendons and this is similar to our results. There is no obvious explanation for why 
the prevalence of ultrasound changes is higher in patellar tendon compared to the quadriceps 
tendon.   
Evidently there is not a one-to-one relationship between pain and structural changes, since 
17% of those with a clinical diagnosis had no ultrasound changes and at any given time 11% 
of asymptomatic tendons displayed ultrasound changes. We cannot recommend instituting 
routine ultrasound screening programs to prevent jumper’s knee when two-thirds of patients 
with hypoechoic areas on their baseline ultrasound examination did not develop symptoms 
during two seasons of intensive training on average. Perhaps improved technology can change 
this recommendation. More advanced ultrasound modalities such as ultrasonographic tissue 
characterization (UTC) may be promising (van Schie et al. 2010).   
3.7 Ultrasound: Tendon adaptation among asymptomatic 
tendons (Paper III) 
 5HVXOWV
Quadriceps tendon thickness increased 7-11% among healthy athletes, while there was no 
change in patellar tendon thickness during a mean observation period of 1.7 years. The 
increase in quadriceps tendon thickness among athletes developing jumper’s knee in their 
patellar tendon was similar in magnitude to that observed in asymptomatic athletes. 
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This is the first study to examine whether tendons hypertrophy in response to intensive 
training during adolescence. The results were somewhat surprising, since an adaptation and 
increase in thickness in both tendons would have been expected considering the large volume 
of training for two seasons. The only longitudinal studies available to date on the patellar 
tendon are on mature athletes and with a much shorter observation period (Kongsgaard et al. 
2007; Kubo et al. 2009; Seynnes et al. 2009; Kubo et al. 2010; Malliaras et al. 2013). Normal 
structural changes from childhood to adulthood are not well characterized and there is a need 
for prospective studies to investigate if the increase in quadriceps tendon thickness is the 
result of intensive training or a consequence of growth and maturation. Mersmann et al. 
(2013) compared a group of adolescent athletes with former top volleyball players. They 
found that even if there was no strength difference in the knee extensors, the adolescent 
athletes featured a smaller tendon CSA. A tendon with larger CSA will have reduced mean 
stress for a given load and therefore, it is possible that differences in tendon dimension may 
play a role in developing tendinopathy. The quadriceps tendon was approximately 50% 
thicker than the patellar tendon and it may be speculated that this difference can provide clues 
as to why the patellar tendon is more susceptible to tendinopathy than the quadriceps tendon.  
This study did not investigate tendon properties and therefore mechanical and material 
properties at baseline were unknown. Helland et al. (2013) found in their case-control study 
based on these athletes, that symptomatic tendons had lower stiffness and Young’s modulus. 
These findings are in contrast to previous findings on the patellar tendon (Kongsgaard et al. 
2009; Kongsgaard et al. 2010; Couppé et al. 2013), but in line with findings in the Achilles 
tendon (Arya and Kulig 2010; Wang et al. 2012). Future prospective studies are needed to 
monitor mechanical properties and their relationship to tendinopathy.  
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3.8 Prevention strategy 
The balance between training hard to achieve results but not so much as to cause an overuse 
injury is difficult. The complex process from a healthy tendon to a symptomatic tendon is not 
fully understood, and more basal research is needed. Based on the evidence presented in 
chapter 1.5 and the results from the current study the major volleyball-specific risk factors of 
developing jumper’s knee are presented in table 6. 
Table 6. Volleyball-specific risk factors for jumper’s knee, the level of evidence is estimated 
as strong, medium, weak or unknown. 
5LVNIDFWRU 'HVFULSWLRQ /HYHORIHYLGHQFH
Gender Males > females Strong (OR: 3-4) 
Tendon load 
     Match exposure 
     Volleyball training 
      (previous and present) 
Per extra set played per week 
Per hour extra training per week 
Strong (OR: 3-4) 
Strong (OR: 2) 
Jumping ability Per cm difference in CMJ at the time of 
inclusion 
Strong (OR: 2) 
Ultrasound findings 
      Hypoechoic areas 
      Neovascularsation 
If hypoechoic areas is present   
If neovascularisation is present  
Medium (OR: 3) 
Medium (OR: 3) 
Court surface Concrete > parquet > sand Strong 
Body composition  Body mass/BMI among adults - not 
adolescents 
Weak 
Genetics Different candidate genes Unknown 
Biomechanics 
      ROM 
      Landing strategy 
Low range of ankle dorsiflexion 
Knee position when landing 
Weak 
Unknown 
Data from the current study suggest that one of the key elements in preventing jumper’s knee 
is to load the tendon appropriately. We found that athletes developing jumper’s knee trained 
more volleyball and played more matches than asymptomatic controls (Paper I). The most 
60
talented boys stand out with a particular risk. Match exposure, i.e. the number of sets played 
per week, was the strongest sports-related predictor for developing jumper’s knee in this 
study. Therefore, one lesson learned from this study is that there needs to be a focus on how 
many different teams youth players should represent during the season and how many 
matches they should play. This issue is unlikely to be raised by the player; this is the 
responsibility of the coaching staff. Jumping ability is another important risk factor (Paper II). 
An obvious explanation for this finding could be that players who jump well subject their 
tendons to higher load with each jump/landing and therefore have higher risk. Athletes could 
jump up to 300 times during a five-game match, while the number of jumps during a regular 
training week is unknown. Reducing the number of jumps may be a controversial strategy, 
but future guidelines might include “jump counts” among adolescent athletes. In baseball, 
safety recommendations have been developed for pitchers, limiting the number of pitches per 
game and number of months played per year from age 14 through 20 years. In volleyball, 
there is currently not enough evidence to introduce jump counts, nor do we know what the 
optimal number of jumps would be. 
We have also investigated if we are able to identify athletes at higher risk by ultrasound 
examinations (Paper III). Even if hypoechoic areas and neovascularization were risk factors 
for developing jumper’s knee, we cannot recommend instituting routine ultrasound screening 
programs to prevent jumper’s knee. 
Another approach would be to add ”tendon strength training” to make tendons strong enough 
to better tolerate the sport-specific activity. Normal tendon adaptation to load is slow 
compared to muscles, especially when athletes rapidly increase the volume of training (Kjaer 
et al. 2009). Imbalances between muscle strength and tendon loading capacity in adolescent 
athletes might increase the risk of tendon injury. Structured warm-up programs, e.g. “the 11+” 
have reduced the risk of lower limb injury (Soligard et al. 2008), including the risk of overuse 
injuries. Other studies also indicate an effect on overuse injuries (Junge et al. 2002; Kraemer 
and Knobloch 2009). Such programs typically combine strength training, stretching, balance 
training, core stability and correct landing strategy after jumps. However, Fredberg et al. 
(2008) found that prophylactic eccentric training increased the risk of patellar tendinopathy. 
So far, the effect of and the potential mechanism behind structured warm-up programs in the 
prevention of overuse injuries like jumper’s knee is unclear. Today there are no guidelines on 
how to make tendons stronger and how to improve tendon properties in a safe manner.  
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To summarize, based on the results of this study a potential prevention strategy would be to 
gradually “develop” athletes rather than to start with too much volleyball-specific training too 
soon. Even though a prevention program should not interfere with the development of the 
sports-specific skills, restrictions on the number of jumps and matches among adolescent 
athletes would probably reduce the risk of jumper’s knee. The problem is that we do not know 
where these limits should be set, and there is insufficient data to adapt programs to the risk 
profile of each athlete. 
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 &RQFOXVLRQV
1. A high volume of volleyball training and match exposure were important risk factors
for developing jumper’s knee. 
2. Body composition or change of body composition was not a risk factor for developing
jumper’s knee among young well-trained athletes. 
3. Volleyball players with a natural ability for jumping high have an increased risk of
developing jumper’s knee, while the change of jumping ability was not identified as a risk 
factor. 
4. Hypoechoic areas and neovascularisation at baseline were risk factors for developing
jumper’s knee. 
5. Quadriceps tendon thickness increased 7-11% among healthy athletes, while there was
no change in patellar tendon thickness during a mean observation period of 1.7 years (two 
volleyball seasons. 
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